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A B S T R A C T
Background
World-wide, cervical cancer is the second most common cancer in women. Increasing the uptake of screening, alongside increasing
informed choice is of great importance in controlling this disease through prevention and early detection.
Objectives
To assess the effectiveness of interventions aimed at women, to increase the uptake, including informed uptake, of cervical cancer
screening.
Search methods
We searched the Cochrane Gynaecological Cancer Group Trials Register, Cochrane Central Register of Controlled Trials (CENTRAL),
Issue 1, 2009. MEDLINE, EMBASE and LILACS databases up to March 2009. We also searched registers of clinical trials, abstracts
of scientific meetings, reference lists of included studies and contacted experts in the field.
Selection criteria
Randomised controlled trials (RCTs) of interventions to increase uptake/informed uptake of cervical cancer screening.
Data collection and analysis
Two review authors independently abstracted data and assessed risk of bias. Where possible the data were synthesised in a meta-analysis.
Main results
Thirty-eight trials met our inclusion criteria. These trials assessed the effectiveness of invitational and educational interventions,
counselling, risk factor assessment and procedural interventions. Heterogeneity between trials limited statistical pooling of data. Overall,
however, invitations appear to be effective methods of increasing uptake. In addition, there is limited evidence to support the use of
educational materials. Secondary outcomes including cost data were incompletely documented so evidence was limited. Most trials
were at moderate risk of bias. Informed uptake of cervical screening was not reported in any trials.
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Authors’ conclusions
There is evidence to support the use of invitation letters to increase the uptake of cervical screening. There is limited evidence to support
educational interventions but it is unclear what format is most effective. The majority of the studies are from developed countries and
so the relevance to developing countries is unclear.
P L A I N L A N G U A G E S U M M A R Y
Invitations and probably educational interventions increase the uptake of Pap smears
Cervical cancer is the second most common cancer world-wide. Increasing the uptake of screening is of great importance in controlling
this disease through early detection and treatment of pre-cancerous changes before malignancy evolves.Methods of encouraging women
to undergo cervical screening include invitations, reminders, education, message framing, counselling, risk factor assessment, procedures
and economic interventions. These were all examined in this review. Evidence supports the use of invitations, and to a lesser extent,
educational materials. It is likely other methods are advantageous, but the evidence is not as strong. Further research is required.
B A C K G R O U N D
Description of the condition
Cervical cancer is the secondmost common cancer among women
(GLOBOCAN 2008). A woman’s risk of developing cervical can-
cer by age 65 years ranges from 0.8% in developed countries to
1.5% in developing countries. Themanagement varies around the
world dependent on resources and policy however the mainstay
of treatment most commonly involves surgery requiring hysterec-
tomy and chemotherapy or radiotherapy. In Europe and the USA,
the 5 year survival rate is between 60% and 72% (EUROCARE
2003; Jemal 2008) and in England and Wales between 2001 and
2006, the 5 year survival rate was 64% (ONS 2010).
Primary and secondary prevention
Human papillomavirus (HPV) infection is believed to be an im-
portant primary cause of cancer of the cervix, with a recent study
estimating the world-wide HPV prevalence in cervical cancers to
be 99.7% (Walboomers 1999). In particular, two subtypes of the
virus HPV (16 and 18) are present in over 80% of invasive cervi-
cal cancers. Other known risk factors for cervical cancer include
smoking (Brinton 1986), the early onset of sexual activity, multi-
ple sexual partners,the presence of other sexually transmitted dis-
eases (STDs) (La Vecchia 1986) and the immunological status of
the woman (Schneider 1983). Individuals who receive immuno-
suppressive therapy for organ transplants and those infected with
human immunodeficiency virus (HIV) are therefore particularly
at risk of developing pre-invasive disease. Primary strategies to pre-
vent the development of cervical cancer focus on reducing these
known risk factors by encouraging a healthy lifestyle, smoking
cessation and the adoption of ’safer’ sexual behaviours aimed at
reducing the risk of HPV infection (Shepherd 2011).
The understanding the role of HPV in cervical cancer has led to
the development of the HPV vaccination. An immunisation pro-
gramme has now been rolled out across many countries. Initial
results are promising, though longer term population studies are
required to assess the wider benefit and provide guidance for fu-
ture changes in screening policy. Until more data from the vac-
cine programmes are available and, in countries that do not have
such programmes secondary prevention methods will need to be
the mainstay of efforts to reduce cervical cancer. These secondary
methods involve screening for the detection of abnormal or pre-
cancerous cell changes (i.e. any changes which may precede, be
associated with or carry a significant risk of developing cancer).
Description of the intervention
Screening
The Papanicolau, or Pap smear, screening test is used world-wide
and is primarily aimed at detecting pre-cancerous changes within
the cervix (i.e. abnormalities in the cells of the cervix known as
dysplasia) before they have an opportunity to progress to invasive
carcinoma. More than 90% of cervical cancers develop within a
small area of the cervix known as the transformation zone and dis-
ease progression from dysplasia to invasive cancer is usually slow,
therefore providing the opportunity to detect and treat pre-can-
cerous disease. During a smear test, cells within the external and
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internal layers of the transformation zone (i.e. ecto- and endo- cer-
vical cells) are collected and subsequently examined for abnormal
cytological changes. The reliability of the technique is however
dependent both on the expertise of the health professional taking
the smear and the individual examining the smear. Even in the
best laboratories, 5 to15% of abnormal smears may be reported as
normal (Nottingham 1998). More recently the use of liquid based
cytology (LBC) has reduced the number of inadequate smears and
subsequent need for recalls (Moss 2004; NICE 2003).
Since the cervical cancer screening programme in 1988, the as-
sociated mortality rate in females under 35 years in the United
Kingdom has fallen (Peto 2004).
World-wide, great variation exists between countries in terms of
the coverage and uptake of cervical cancer screening. In a number
of countries including the UK, Finland, Australia, Sweden and
Spain, national cervical cancer screening programmes have been
introduced. Such screening programmes are usually aimed at those
women most at risk of developing cervical cancer (i.e. usually
women aged between 20 and 65 years). Recommendations vary
between countries, but women are usually screened every one to
five years. In many other countries Pap smear services are provided
on a much more local basis, if at all.
Pap smear uptake and coverage not only vary between countries,
but differences also exist within countries between different socio-
demographic groups, according to factors including ethnic origin,
age, education and socio-economic status. Lower uptake rates have
been found to occur in those women who are older, less well-
educated, from lower socio-economic groups or who reside in rural
locations (Brinton 1994; Ries 1999). Certain ethnic groups have
also been identified as having lower rates of Pap smear uptake,
such as African-American, Hispanic and Native American in the
USA and Asian women in the UK (Luke 1996; Miller 1994). In
many cases therefore, interventions have been aimed at trying to
increase screening amongst these groups of women. Thus there
are a number of factors to consider when developing interventions
to increase the uptake of Pap smear screening. These factors are
likely to differ between developing and developed countries and
between individual populations in a country.
Encouraging the uptake of screening
One of the major obstacles to the success of cervical cancer screen-
ing worldwide is the uptake of the programme by women. Un-
derstanding the various reasons for women not ever attending a
smear or failing to continue in further rounds of screening are dif-
ficult to assess. Much work across the world has been undertaken
to determine contributing factors, such as cost, anxiety, embar-
rassment, and fear of cancer. Women from ethnic minorities and
deprived sub-groups in the population have shown consistently
lower uptake over decades of screening in countries worldwide
(Moser 2009; Webb 2004). This may be attributable to health
literacy especially since screening literature can include complex
concepts. HPV is transmitted sexually and therefore screening and
cervical cancer itself can be perceived as a consequence of promis-
cuity and thus have negative connotations. Encouragingly though,
in a recent survey of Muslim Turkish women who mostly accept
talking about sex as a taboo, the majority of women felt the rec-
ommendations from health workers was the major influence in
attending screening and accepting the HPV vaccination for their
daughters (Ilter 2010). Given the complex nature of the factors
involved a number of interventions have therefore been based on
theoretical models of health behaviour, such as the Health Be-
lief Model (Kreuter 1996; Marcus 1992) and the Transtheoretical
Model (Rimer 1999). It is important to realise that because of
differences between populations, interventions that are effective
in one setting may not be as effective in another.
In the UK, websites such as that provided by the NHS Cervical
Screening Programme can go some way to trying breaking down
barriers to screening. The website provides written, audio and vi-
sual resources aimed at answering common concerns, explaining
the procedure and explanation of results. Key documents are pro-
vided in a translated format covering many languages spoken by
the larger minority groups in the UK.
How the intervention might work
Informed consent
The main focus of attention of cervical screening programmes is
to increase the uptake of cervical screening. However, this must
be done in the context of informed consent and understanding
of the screening tests. It is recognised that both informed uptake
and consent is important since screening can cause harm with in-
evitable false negatives leading to women being wrongly reassured
and false positives resulting in unnecessary anxiety and further in-
vestigations and possibly even treatment. In particular, informed
uptake needs to be considered especially when topical media cov-
erage, exemplified by the cervical cancer sufferer Jade Goody in
the UK, can result in such an increase in women attending screen-
ing whether required or not (an increase of 3.6 million women
screened in 2008/09 compared to 3.2million in the previous year)
yet the numbers soon fall when the media interest settles (3.3.
million women screened in 2009/10). (NHS Information Centre
2010).
Why it is important to do this review
The incidence of cervical cancer is reduced by 93.5%, 92.5%,
90.8%, 83.6% and 64.1% if women have screening every year,
every 2 years, every 3 years, every five years and every 10 years
respectively; these screening intervals would mean women having
50, 25, 16, 10 and 5 smear tests respectively in their lifetime
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(IARC 1986). More recently, through modelling analyses, it has
been shown that extending the re-screening interval from one year
to every three years results in an average excess risk of about 3
per 100,000 (Sawaya 2003). In the UK women aged 25 to 50 are
invited for screening every three years and those aged 50 to64 every
five years. Each year, around 3.5 million women accept screening
(NHS Information Centre 2010) and this has been estimated to
prevent up to 3900 cases of cervical cancer and save over 4500 lives
annually in UK (Peto 2004; Sasieni 1996). However, despite its
effectiveness, the uptake rate of cervical cancer screeningby eligible
women remains stubbornly below80% (NHS Information Centre
2010). Information is needed to establish what can be done to
increase this uptake rate, particularly in the 20% of women who
are missing out on screening.
O B J E C T I V E S
To assess the effectiveness of interventions aimed at women, to
increase the uptake, including informed uptake, of cervical cancer
screening.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) and cluster RCTs of univer-
sal, selective or opportunistic cervical cancer screening.
Types of participants
All women eligible to participate in a cervical cancer screening
programme as defined by the entry criteria for that programme.
Women due or overdue were all considered for inclusion.
Types of interventions
All interventions targeted at women who are eligible for screen-
ing. Interventions aimed at communities such as mass media cam-
paigns (Grilli 2002) and those aimed at health professionals were
excluded as they are considered in other Cochrane reviews. In-
terventions targeted at health professionals that are covered in
other Cochrane reviews include: audit and feedback (Jamtvedt
2006), educational outreach visits (O’Brien 1997), printed educa-
tional materials (Freemantle 1997), computer-generated paper re-
minders (Arditi 2010), manual paper reminders (Romero 2004),
on-screen computer reminders (Gordon 1998), and other inter-
ventions (Hulscher 2006).
For the sub-group analyses the interventions were categorised as
follows (Jepson 2000):
• Invitations
◦ Invitations to women due for screening (either first
round or second round). Does not include women who are
overdue for screening. Includes fixed or open appointments,
letters, telephone calls, verbal recommendations, prompts and
follow-up letters.
• Reminders
◦ Reminders to women who are overdue for screening
and have not responded to the first round of screening. Includes
fixed or open appointments, letters, telephone calls, verbal
recommendations, prompts and follow-up letters.
• Education
◦ Educational interventions aiming to increase
knowledge of the screening programme or the disease being
screened for, that do not contain a counselling component.
Includes printed educational materials, audio-visual materials,
group and individual teaching and home visits.
• Message Framing
◦ Messages about screening (either verbal or written)
that are framed either positively or negatively.
• Counselling
◦ Counselling either face-to-face or on the telephone.
Must involve a discussion of barriers to screening as well as an
educational component.
• Risk Factor Assessment
◦ Risk factor questionnaires and computer programmes
assessing a person’s risk status.
• Procedures
◦ Interventions to increase screening uptake by making
the screening procedure easier or more acceptable to individuals
undergoing screening. Includes different screening tests for the
same disease, or length of time that screening test takes, and
opportunistic testing and notification of results.
• Economic
◦ Removal of financial barriers or economic incentives.
Includes reduced cost or free screening tests, transport costs, free
postage for returning tests and ’rewards’ for completion of a
screening test.
Controls
• Control groups are those with no intervention or no
intervention other than that routinely undertaken by the local
screening program.
Types of outcome measures
Trials that reported one or more of the following primary outcome
measures were included:
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Primary outcomes
• Uptake or non-uptake of cervical screening as recorded by
health service records (such as screening administration system,
hospital or primary care physician records)
• Uptake or non-uptake of cervical screening as collected via
self-report (i.e. directly reported by the participant in a telephone
interview or questionnaire)
Secondary outcomes
The following intermediate and other outcomes were considered,
if reported:
• Booking of appointments;
• Reported intentions to attend screening;
• Attitudes to screening;
• Knowledge of screening;
• Satisfaction with screening service;
• Costs of the interventions.
Search methods for identification of studies
Papers in all languages were sought and translations carried out
when necessary.
Electronic searches
See: Cochrane Gynaecological Cancer Groupmethods used in re-
views.
The following electronic databases were searched:
TheCochraneCentral Register of ControlledTrials (CENTRAL),
Issue 1, 2009. Cochrane Gynaecological Cancer Collaborative Re-
view Group’s Trial Register MEDLINE (1966 to March 2009),
EMBASE (1985 to March 2009) and LILACS.
The MEDLINE, EMBASE, CENTRAL and LILACS search
strategies aiming to identify RCTs comparing interventions tar-
geted at women to encourage the uptake of cervical screening
before March 2009 are presented in Appendix 1, Appendix 2,
Appendix 3 and Appendix 4 respectively.
Databases were searched from January 1966 until March 2000 in
the original review (based on the comprehensive search strategy
developed for the HTA review (Jepson 2000)) and up to March
2009 in this updated version.
All relevant articles found were identified on PubMed and using
the ’related articles’ feature, a further search was carried out for
newly published articles.
Searching other resources
Unpublished and Grey literature
Metaregister, Physicians Data Query, www.controlled-trials.com/
rct, www.clinicaltrials.gov and www.cancer.gov/clinicaltrials were
searched for ongoing trials. The main investigators of the relevant
ongoing trials were contacted for further information, as were the
major co-operative trials groups active in this area.
Published and unpublished studies were included, if they met the
inclusion criteria for the review.
Reference lists and Correspondence
The citation lists of included trials were checked and experts in
the field contacted to identify further reports of trials.
Data collection and analysis
Selection of studies
All titles and abstracts retrieved by electronic searchingwere down-
loaded to the reference management database (Endnote), dupli-
cates were then removed and the remaining references examined
by four review authors (TE, AB, YLW,MK) independently. Those
studies which clearly did not meet the inclusion criteria were ex-
cluded and copies of the full text of potentially relevant references
were obtained. The eligibility of retrieved papers was assessed inde-
pendently by two review authors (TE, MG). Disagreements were
resolved by discussion between the two review authors and when
necessary by a third review author (AB). Reasons for exclusion are
documented.
Data extraction and management
For included trials, the following data were abstracted:
• Author, year of publication and journal citation (including
language)
• Country
• Setting
• Inclusion and exclusion criteria
• Study design, methodology
• Study population
◦ Total number enrolled
◦ Patient characteristics
◦ Age
• Total number of intervention groups
• Intervention details
◦ Type of intervention
◦ Description of intervention
◦ Frequency and duration of intervention
◦ Type of healthcare professional who provided the
intervention
• Control details
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◦ Any other reported information other than no active
intervention was given
• Risk of bias in study (see below)
• Duration of follow-up
• Outcomes - Uptake or non-uptake of cervical screening,
booking of appointments, reported intentions to attend
screening, attitudes to screening, knowledge of screening,
satisfaction with screening service, costs of the interventions.
• For each outcome: Outcome definition;
• Unit of measurement (if relevant);
• For scales: upper and lower limits, and whether high or low
score is good;
• Results: Number of participants allocated to each
intervention group;
• For each outcome of interest: Sample size; Missing
participants.
Data on outcomes were extracted as below:
• For dichotomous outcomes (e.g. Uptake or non-uptake),
we extracted the number of women in each treatment arm who
underwent screening for cervical cancer and the number of
women assessed at endpoint, in order to estimate a risk ratio.
Where possible, all data extracted were those relevant to an in-
tention-to-treat analysis, in which participants were analysed in
groups to which they were assigned.
The time points at which outcomes were collected and reported
was noted.
Data were abstracted independently by two reviewers (TE, AB)
onto a data abstraction form specially designed for the review.
Differences between reviewers were resolved by discussion.
Assessment of risk of bias in included studies
The risk of bias in included RCTs was assessed using the Cochrane
Collaboration’s tool. This included assessment of:
• sequence generation
• allocation concealment
• blinding (Assessment of blinding was restricted to blinding
of outcome assessors)
• incomplete outcome data: We recorded the proportion of
participants whose outcomes were not reported at the end of the
study and noted whether loss to follow-up was not reported. We
coded a satisfactory level of loss to follow-up for each outcome as:
• ◦ Yes, if fewer than 20% of patients were lost to follow-
up and reasons for loss to follow-up were similar in both
treatment arms
◦ No, if more than 20% of patients were lost to follow-
up or reasons for loss to follow-up differed between treatment
arms
◦ Unclear if loss to follow-up was not reported
• selective reporting of outcomes
• other possible sources of bias
The risk of bias tool was applied independently by two review
authors (TE, AB) and differences resolved by discussion. Results
are presented in both a risk of bias graph and a risk of bias summary
(See Figure 1; Figure 2). Results of meta-analyses were interpreted
in light of the findings with respect to risk of bias.
Figure 1. Methodological quality graph: review authors’ judgements about each methodological quality
item presented as percentages across all included studies.
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Figure 2. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study.
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Measures of treatment effect
We used the following measures of the effect of treatment:
• For dichotomous outcomes (e.g. uptake or non-uptake), we
used the risk ratio
Dealing with missing data
We did not impute missing outcome data for the primary out-
come. If data were missing or only imputed data were reported
we contacted trial authors to request data on the outcomes only
among participants who were assessed.
Assessment of heterogeneity
Heterogeneity between trials was assessed by visual inspection of
forest plots, by estimation of the percentage heterogeneity between
trials which cannot be ascribed to sampling variation (Higgins
2003), by a formal statistical test of the significance of the het-
erogeneity (Deeks 2001) and, if possible, by sub-group analyses
(see below). If there was evidence of substantial heterogeneity, the
possible reasons for this were investigated and reported.
Assessment of reporting biases
Funnel plots corresponding to meta-analysis of the primary out-
come were examined to assess the potential for small study effects.
When there was evidence of small-study effects, publication bias
was considered as only one of a number of possible explanations.
If these plots suggested that treatment effects may not be sam-
pled from a symmetric distribution, as assumed by the random ef-
fects model, sensitivity analyses were performed using fixed effects
models.
Data synthesis
If sufficient, clinically similar studies were available their results
were pooled in meta-analyses.
• For dichotomous outcomes, the risk ratios were pooled.
For trials with multiple treatment groups, the ‘shared’ comparison
group was divided into the number of treatment groups and com-
parisons between each treatment group and the split comparison
group were treated as independent comparisons.
A random effects model with inverse variance weighting was used
for all comparisons (DerSimonian 1986).
Where interventions differed to any degree or there was other
substantial heterogeneity the results were reported in a narrative.
For cluster randomised controlled trials, if the analysis accounted
for the cluster design then a direct estimate of the desired treatment
effect was extracted e.g. RR plus 95% CI. If the analysis did not
account for the cluster design, we extracted the number of clusters
randomised to each intervention, the average cluster size in each
intervention group and the outcome data, ignoring the cluster de-
sign, for all women in each group. Next, using an external estimate
of the intracluster coefficient (ICC) a design effect was estimated.
Hence, the variance of the effect estimate was inflated. It was then
possible to enter the data into RevMan 5 and combine the cluster
randomised trials with individually randomised trials in the same
meta-analysis, using the generic inverse variance method of meta-
analysis.
Subgroup analysis and investigation of heterogeneity
Subgroup analyses were performed according to the different cat-
egories of intervention type.
Sensitivity analysis
We intended to repeat the meta-analyses excluding: trials at high
risk of bias; and examine very large trials separately to determine
their overall influence. However, all trials were at moderate or high
risk of bias so consequently we did not perform sensitivity analyses.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
Results of the search
Over 46,000 titles and abstracts (where available) were screened
for the original HTA review covering all screening tests, of which
440 full paper copies were then further assessed for inclusion in
the original review. For the review update, a further 1886 titles and
abstracts were screened and 78 full paper copies were then further
assessed. Forty-two of these papers, specifically focused on cervical
cancer screening and appeared to fulfil the inclusion criteria. In
order to confirm that trials met the inclusion criteria for analysis,
additional information was requested from the authors of 42 tri-
als (37 authors). Replies were received from 20 of the trials (17
authors). In total 102 articles were retrieved in full and translated
into English where appropriate and up-dated versions of relevant
trials were identified. The full text screening of these 102 refer-
ences excluded 64 of them for the reasons described in the table
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Characteristics of excluded studies. However 38 completed RCTs
were identified that met our inclusion criteria and are described
in the table Characteristics of included studies.
In total thirty eight trials, randomising a total of 159,728 women,
met all of the inclusion criteria and were included in this review.
Included studies
(See Characteristics of included studies)
Thirty-eight RCT’s were included in the review, including six
cluster RCTs (Byles 1994; Byles 1995; Byles 1996; Mock 2007;
Navarro 1995; Ornstein 1991. Sixteen of the trials were per-
formed in the USA (Allen 2001; Binstock 1997; Burack 1998;
Burack 2003; Clementz 1990; Greene 1999; Kreuter 1996; Mock
2007; Navarro 1995; Ornstein 1991; Rimer 1999; Rivers 2005;
Somkin 1997; Sung 1997; Taylor 2002; Vogt 2003), nine in
Australia (Bowman 1995; Byles 1994; Byles 1995; Byles 1996;
Del Mar 1998; Hunt 1998; Morrell 2005; Pritchard 1995; Ward
1991), seven in the UK (Adab 2003; Lancaster 1992; McAvoy
1991; Pierce 1989; Robson 1989; Stein 2005; Wilson 1987),
two in Canada (Buehler 1997; McDowell 1989), two in Swe-
den (Eaker 2004; Oscarsson 2007), one in South Africa (Risi
2004) and one in Italy (Segnan 1998). The majority of the trials
were set in community clinics and primary care practices. How-
ever, five of the trials based in the USA were set in Health Main-
tainance Organisations (HMOs) (Binstock 1997; Burack 1998;
Burack 2003; Somkin 1997; Vogt 2003), and two of the UK trials
were based around the UK national cervical screening programme
(McAvoy 1991; Wilson 1987). The trial set in Italy was also based
around a national cervical screening program (Segnan 1998). In
addition five trials were aimed at specific ethnic populations in-
cluding Asian women (McAvoy 1991), Afro-American women
(Sung 1997), Vietnamese-American women (Mock 2007), Chi-
nese women (Taylor 2002) and Latinas (Navarro 1995). Twenty-
one trials had more than two arms (Binstock 1997; Bowman
1995; Burack 1998; Byles 1994; Byles 1995; Byles 1996; Greene
1999;Hunt 1998; Kreuter 1996;McAvoy 1991;McDowell 1989;
Ornstein 1991; Pierce 1989; Pritchard 1995; Rimer 1999; Rivers
2005; Segnan 1998; Somkin 1997; Stein 2005; Taylor 2002; Vogt
2003); the remaining seventeen trials had only two arms and thus
just one comparison.
Invitations
Seventeen trials evaluated the effectiveness of invitation letters
(Binstock 1997; Byles 1994; Byles 1995; Byles 1996; Bowman
1995; Buehler 1997; Burack 1998; Clementz 1990; Del Mar
1995; Hunt 1998; Lancaster 1992; McDowell 1989; Ornstein
1991; Pierce 1989; Pritchard 1995; Segnan 1998; Wilson 1987).
The trials were subdivided according to the invitation type (i.e.
GP letter, letter from another authority source, face-to-face invi-
tation, open invitation and invitation with fixed appointment).
Comparison groups included different types of invitation or a con-
trol group (usually consisting of usual care or no intervention).
Two trials (n = 4370 participants in total) evaluated invitations
from different authority sources (Bowman 1995; Segnan 1998),
and the use of letters with appointments to attend for screening;
two additional studies also evaluated the use of letters with ap-
pointments (Pritchard 1995;Wilson 1987). Three trials (n = 3086
participants in total) examined the use of letter with open invita-
tions to make appointments versus control (usual care) (Bowman
1995; Pritchard 1995; Somkin 1997).
Two trials looked at telephone invitations (n = 5652 participants
in total) (Binstock 1997;McDowell 1989), whereas another study
(n = 121 participants in total) looked at face-to-face invitations
from a health worker or GP (Hunt 1998).
Education
Three trials evaluated printed materials (McAvoy 1991; Bowman
1995; Rimer 1999), two were face-to-face home visit trials
(McAvoy 1991, Sung 1997) and one trial (n = 176 participants)
did not report in detail the type of educational intervention used
(Greene 1999).One cluster randomised trial adequately accounted
for the clustering in its analyses, but the data reported was not
suitable for calculating risk ratios (Navarro 1995).
Counselling
Two trials examined the use of counselling (n = 599 participants
in total). One compared face-to-face counselling by a GP with
no counselling (Ward 1991); the other compared telephone coun-
selling and patient prompts, versus patient prompts alone (control
group) and provider prompts alone (Rimer 1999).
Risk Factor Assessment
Two trials (n = 1590 in total) evaluated risk factor assessment
(Greene 1999; Kreuter 1996). Both used an enhanced risk fac-
tor assessment that involved a personally tailored assessment and
discussion with the health care provider about the woman’s per-
sonal risk factors for developing cervical cancer. Both interventions
were based on theoretical models of behaviour, the Social Cog-
nitive Theory and Motivational Interviewing Methods (Greene
1999) and the Health BeliefModel (Kreuter 1996), with a view to
changing behaviour to increase the uptake of Pap smears. One trial
(Greene 1999) compared the intervention (n = 97) to usual care
(n = 79) whereas the other trial (Kreuter 1996) (n = 1317, 206/
1317 analysed) compared the intervention to a no intervention
control group (Kreuter 1996). Similarly, this trial also compared
enhanced risk factor assessment with a less intense ’typical’ risk
factor assessment. The typical risk factor assessment involved sup-
plying the participant with their personal risk factor information
but not discussing the information provided.
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Procedures
Only one procedure was identified; access to a health prevention
nurse (Robson 1989). There were two quasi-RCTs that examined
the uptake of screening where the gender of the smear taker was
revealed in the invitation letter and access to a lay health worker
who offered women screening with a female nurse practitioner
(Hicks 1997; Margolis 1998), but no RCTs were found.
Secondary outcomes
A summary of the data relating to secondary outcomes is presented
in Table 1.
One trial (n =273) used the booking of appointments for screening
as an outcome measure (Greene 1999).
One trial (n = 3094) examined participants attitudes to Pap smear
screening (Byles 1995).
Five trials (n = 7718 participants in total) presented cost data
(Binstock 1997; McDowell 1989; Oscarsson 2007; Stein 2005;
Vogt 2003). Many of the trials used multiple intervention groups
but only those groups that used an intervention aimed at women
(and not healthcare providers) were included in this review.
Excluded studies
The sixty-four references excluded after assessing full paper copies
are listed in the Characteristics of excluded studies table, with
reasons for their exclusion. Fifteen were quasi randomised (Baele
1998; Chumworathayi 2007; Hicks 1997; Hou 2002; Hou 2005;
Lantz 1995; Lantz 1996; Levine 2003; Marcus 1992; Margolis
1998; Maxwell 2003; Park 2005; Paskett 1990; Ward 1999;
Yancey 1995), three studies included participants who may have
been screened before receiving the intervention (Dignan 1996;
Dignan 1998; Gotay 2000), ten studies used an intervention
aimed at either the physician or both the physician and patient
(Boissel 1995; Bonevski 1999; Campbell 1997; Cecchini 1989;
Hillman 1998; Litzelman 1993; Manfredi 1998; Nguyen 2000;
Roetzheim 2004; Roetzheim 2005), seven studies used an inter-
vention or an outcome that was not strictly concerned with in-
creasing uptake (Brewster 2002; Del Mar 1995; Holloway 2003;
Katz 2007; Paul 2003; Philips 2006; Sankaranarayanan 2003;),
nine studies concerned intervention aimed at improving follow-
up of an abnormal smear results rather than initial Pap screening
uptake (Engelstad 2005; Lauver 1990;Marcus 1998;Miller 1999;
Paskett 1995; Peters 1999; Stewart 1994; Takacs 2004; Tomlinson
2004), four studies presented in a way that was not usable for
the purposes of the review (Corkrey 2005; Hancock 2001; Lynch
2004; Newell 2002), three studies were excluded they included
women over the upper age limit of most routine cervical screening
programmes (Mayer 1992; Ruffin 2004; Valanis 2003) two stud-
ies did not separate attendance for cervical cancer screening from
other screening tests (Mitchell 1991; Powers 1992) and ten studies
did not use a randomised design (Al Saifafi 2009; German 1995;
Jenkins 1999; Karwalajtys 2007; Miller 2007; Mitchell 1997;
Paskett 1999; Perkins 2007; Shelley 1991; Torres-Mejia 2000),
one study (Lam 2003) presents initial data only that is included
elsewhere (Mock 2007). The trial of Peters 1999 was a cluster RCT
examining anxiety among women with mild dyskaryosis and the
aim of the educational intervention was to reduce anxiety so scope
differs to that of this review.
Risk of bias in included studies
(See Risk of Bias tables in Characteristics of included studies)
All trials were at moderate risk of bias: Hunt 1998 satisfied three
of the criteria that we used to assess risk of bias, whereas the other
trials, at most, satisfied only two of the criteria. Eight trials failed
to fulfil any of the criteria adequately (Byles 1994; Byles 1995;
Byles 1996; Greene 1999; Kreuter 1996; Navarro 1995; Rimer
1999; Sung 1997).
Allocation
Twelve trials used an adequate method of generation of the se-
quence of random numbers to allocate women to treatment arms
(Adab 2003; Buehler 1997; Burack 1998; Clementz 1990; Hunt
1998; McAvoy 1991; Oscarsson 2007; Pritchard 1995; Rivers
2005; Robson 1989; Segnan 1998; Stein 2005). The method of
randomisation was unclear in the remaining twenty-six trials that
did not report the method of randomisation.
In the trial of Eaker 2004 “collaborators in the trial were blinded
to the women’s group assignment”. Concealment of allocation was
satisfactory in the trial of Wilson 1987, as this trial used a cen-
tralised independent randomisation and allocation service which
was protected from any potential tampering by those involved in
the study. In the trial of Clementz 1990 treatment allocation was
not concealed and was not reported in any of the other thirty-five
trials.
Blinding
The outcome assessor was blinded to the treatment allocation in
only three trials (Bowman 1995; Del Mar 1998; Hunt 1998). It
was unclear in the remaining thirty-five trials whether the outcome
assessor was blinded as it was not reported.
Incomplete outcome data
Loss to follow up was low in twenty-eight of the trials, with at
least 80% of women being assessed at the end of the study. It was
unsatisfactory in ten trials (Allen 2001; Bowman 1995; Burack
1998; Kreuter 1996; Navarro 1995; Rimer 1999; Rivers 2005;
Stein 2005;Sung 1997; Vogt 2003), as less than 80% of women
were assessed at endpoint in at least one of the outcomes and was
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unclear in the remaining four trials (Byles 1994; Byles 1995; Byles
1996; Greene 1999).
Selective reporting
In all thirty-eight trials it was unclear as to whether outcomes had
been selectively reported as there was insufficient information to
permit judgement.
Other potential sources of bias
In thirty-five trials there was insufficient information to assess
whether any important additional risk of bias existed. The trial
of Robson 1989 was potentially biased as it stopped early because
participating doctors were not prepared to continue excluding half
the practice from access to the health promotion nurse. In Rivers
2005 the women received a telephone call at 6months to ascertain
screening uptake and this may itself have acted as a prompt for
non-attenders to attend for screening and as such influenced the
12 month data. Women were selected from the social networks of
the lay health outreach workers in Mock 2007 and therefore may
be more motivated to comply.
Effects of interventions
We did not include any of the cluster RCTs (Byles 1994; Byles
1995; Byles 1996; Mock 2007; Navarro 1995; Ornstein 1991) in
any of themeta analyses because it was either not possible to extract
binary data, interventions or/and outcomes differed sufficiently
or a satisfactory estimate of the ICC could not be obtained. We
obtained values of the ICC that ranged from 0.02 to 0.29 (Hade
2010). When 0.02 was used as the ICC for the trial of Byles 1996
we got an estimated design effect of 109 due to the average cluster
size being large, which considerably decreased the effective sample
size. Since the unit of randomisation was postal codes we would
not expect a large ICC, but do not have estimates from any pilot
studies so have reported cluster RCTs as single trial narratives due
to the uncertainty in reducing the effective sample size.
Uptake of screening
Invitations
Invitation versus control
A funnel plot corresponding to the invitation versus control sub-
group in the above meta-analysis showed no evidence of bias in
small studies (see Figure 3). Funnel plots were not computed else-
where in the analyses as there were insufficient trials in which to
draw valid conclusions. Analysis 1.1
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Figure 3. Funnel plot of comparison: 1 Invitation vs control, outcome: 1.1 Uptake of screening.
Invitation letter versus control
Meta-analysis of twelve trials (Binstock 1997; Bowman 1995;
Buehler 1997; Burack 1998; Burack 2003; Del Mar 1998; Hunt
1998; Lancaster 1992; McDowell 1989; Morrell 2005; Pierce
1989; Stein 2005), assessing 99,651 participants, found that
women who received invitation letters to attend cervical screen-
ing programmes had a significantly higher uptake of screening
than women who received usual care or no invitation (RR= 1.44,
95% CI: 1.24 to 1.52). The percentage of the variability in ef-
fect estimates that is due to heterogeneity rather than sampling
error (chance) may represent substantial heterogeneity (I2 = 72%).
(comparison 1.1.1)
Telephone invitation versus control
Meta-analysis of four trials (Binstock 1997; McDowell 1989;
Stein 2005; Vogt 2003), assessing 2342 participants, found that
women who received a telephone invitation had a significantly
higher uptake of screening than those in the control group (RR=
2.16, 95% CI: 1.70 to 2.74). The percentage of the variability
in effect estimates that is due to heterogeneity rather than chance
may represent moderate heterogeneity (I2 = 21%). (comparison
1.1.2)
Face to face invitation versus control
The trial of Hunt 1998, which assessed 121 participants, found
no statistically significant difference in the uptake of screening be-
tween women who received a face to face invitation and those in
the control group (RR = 9.15, 95%CI: 0.50 to 166.30). However,
only four out of the 121 women attended for screening. (compar-
ison 1.1.3).
Letter with open invitation to make appointment versus
control
Meta-analysis of four trials (Bowman 1995; Pritchard 1995;
Somkin 1997; Vogt 2003), assessing 2998 participants, found that
women who received letters with an open invitation to attend a
cervical screening programme had significantly higher uptake of
cervical screening than women in the control group (RR= 1.61,
95% CI: 1.15 to 2.26). The percentage of the variability in effect
estimates that is due to heterogeneity rather than chance may rep-
resent moderate heterogeneity (I2 = 50%).
The cluster RCT of Byles 1996 reported results of a mass mailing
campaign to promote screening. The intervention letter provided
information on the screening services available in the local area
and included an invitation to enrol with the Pap smear reminder
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service. In the intervention arms, women were either sent a per-
sonalised letter with the initial invitation or three years later, with
the reminder invitation. A control group received no letter at all.
Significant increases in screening rates were observed in those re-
ceiving a personalised letter with the initial invitation.
Similarly the Byles 1995 cluster RCT assessed the effectiveness of
two direct mail strategies to encourage women to have Pap smears
compared to a control. The two strategies were assessed in two
geographically separated postal regions in Australia. The first in-
tervention consisted of a personally addressed letter providing ba-
sic information about Pap smears, information on screening, ad-
vice, lists of local providers and an invitation to enrol with free
Pap reminder service. The second intervention, in addition to the
letter, included a multi-faceted intervention package designed to
address a number of factors associated with screening behavior.
The effectiveness of each strategy was assessed using a multiple
group time-series design involving three postal regions. Both in-
terventions resulted in statistically significant increases in atten-
dances for screening over the post intervention period (42.2% in
the region receiving the simple prompt and 39.6% in the region
receiving the multi-faceted approach).
The cluster RCT of Ornstein 1991 assessed the effectiveness of
three interventions that aimed to encourage uptake of various
screening/vaccine sessions, including a Pap smear. Patients and
their physicians were randomly assigned by practice group into
one of four groups which included physician reminders, patient
reminders, patient and physician reminders and a control group.
The authors concluded that computer based physician and patient
reminder systems improved adherence to preventive services in pri-
mary care settings. In this one year study, a statistically significant
decline in Pap smear adherence was confined to the physician re-
minder group. Small, inconsistent declines in adherence occurred
in all four groups. These declines were significant only for white
women. (comparison 1.1.4).
Letter with fixed appointment versus control
In the trial of Pritchard 1995, which assessed 177 participants,
women who received letters with a fixed appointment to attend
a cervical screening programme had a significantly higher uptake
of screening than the control group (RR = 1.80, 95% CI: 1.04 to
3.11). (comparison 1.1.5).
Letter invitation with telephone follow up versus control
The trial of Vogt 2003, which assessed 276 participants, found a
significant difference in the uptake of screening between women
who received a face to face invitation and those in the control
group (RR = 3.14, 95% CI: 1.97 to 5.01). (comparison 1.1.6).
Celebrity invitation versus control
The trial of Stein 2005 which assessed 316 participants, found no
statistically significant difference in the uptake of screening be-
tween women who received a celebrity endorsed letter of invita-
tion and those in the control group (RR = 2.15, 95% CI: 0.25 to
18.15). (comparison 1.1.7)
GP invitation letter versus invitation letter from other
authority sources
The trial of Bowman 1995, which assessed 86 participants, found
little difference between GP invitation letters and health clinic
invitation letters in the uptake of cervical screening (RR = 1.69,
95% CI: 0.75 to 3.82).
In the trial of Segnan 1998, which assessed 4028 participants,
women who received GP letters to attend a cervical screening pro-
gramme had a significantly higher uptake of screening than those
who received invitation letters from programme coordinators (RR
= 1.13, 95% CI: 1.05 to 1.21). Analysis 2.1
Personal invitation versus invitation letter
Meta-analysis of two trials (Binstock 1997; McDowell 1989), as-
sessing 1899 participants, found that women who received tele-
phone invitations to attend a cervical screening programme had a
significantly higher uptake of screening than women given invi-
tation letters (RR = 1.32, 95% CI: 1.15 to 1.53). The percentage
of the variability in effect estimates that is due to heterogeneity
rather than chance is not important (I2 = 0%).
The trial of Hunt 1998, which assessed 123 participants, found no
statistically significant difference between face to face invitations
and invitation letters in the uptake of cervical screening (RR =
2.10, 95% CI: 0.40 to 11.05). Analysis 3.1
Letter with fixed appointment versus letter with open
invitation to make an appointment
Meta-analysis of four trials (Bowman 1995; Pritchard 1995;
Segnan 1998; Wilson 1987), assessing 4706 participants, found
that women who were given letters with a fixed appointment to
attend a cervical screening programme had a significantly higher
uptake of screening thanwomen who received letters with an open
invitation (RR= 1.57, 95% CI 1.43 to 1.72). The percentage of
the variability in effect estimates that is due to heterogeneity rather
than chance is not important (I2 = 0%). Analysis 4.1
Three way comparison of television media, television media
combined with invitation letter and television media
combined with GP based recruitment
The cluster RCT of Byles 1994 assessed the effectiveness of three
community based strategies to promote screening for cervical can-
cer. A trial of each television media intervention was carried out
in three postal regions in New South Wales - a rural locality, a
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country town and a major rural centre. Three control regions were
selected to be demographically similar to the corresponding re-
gions. Television media alone was associated with a significant in-
crease in attendances for screening in the rural centre. The media/
letter based campaign was associated with a significant increase in
attendances in the rural locality and rural centre. The media/GP
based campaign was associated with significant increases in atten-
dances in all three regions. All three interventions were associated
with significant increases in the number of women attending for
screening above those observed in the control regions. Further-
more, these increases were not restricted to women at low risk.
They were also found for older women (aged 50 to 69 years) and
women who had not had a Pap smear within the past three years.
Education
Education versus control
Education (printed material) versus control
Meta-analysis of three trials (Bowman 1995;McAvoy 1991; Rimer
1999), assessing 502 participants, showed little difference in the
uptake of screening betweenwomenwho received printedmaterial
as a form of education and those in the control group (RR= 1.11,
95% CI: 0.88 to 1.41). The percentage of the variability in effect
estimates that is due to heterogeneity rather than chance is not
important (I2 = 0%). Analysis 5.1
Education (miscellaneous) versus control
Meta-analysis of two trials (Greene 1999;Taylor 2002), which as-
sessed 295 participants showed a significantly higher uptake of
screening inwomen in the education group compared towomen in
the control group (RR = 1.92, 95%CI 1.24 to 2.97). The percent-
age of the variability in effect estimates that is due to heterogeneity
rather than chance is not important (I2 = 0%). Women were given
an educational exercise (format unknown) (Greene 1999) or a va-
riety of educational materials (Taylor 2002), aimed at increasing
awareness of cervical screening programme (comparison 5.1.2).
Education (miscellaneous) versus control
Meta-analysis of three trials (McAvoy 1991; Sung 1997; Taylor
2002), assessing 1318 participants, showed a significantly higher
uptake of screening in women who received face to face home
visits as a form of education compared to those in the control
group (RR = 2.33, 95% CI: 1.04 to 5.23). The percentage of the
variability in effect estimates that is due to heterogeneity rather
than chance may represent considerable heterogeneity (I2 = 79%)
(comparison 5.1.3).
Education versus other
The trial of Bowman 1995, which assessed 99 participants, showed
little difference in the uptake of screening between women who
received printed material as a form of education and those who
received a health clinic invitation letter (RR= 1.08, 95% CI: 0.45
to 2.61). Similarly there was no statistically significant difference
in the uptake of screening between printed material and GP invi-
tation letters (RR= 0.64, 95% CI: 0.31 to 1.32).
The trial of Greene 1999, which assessed 98 participants, found
little difference in the uptake of cervical screening between educa-
tion (format unknown) aimed at increasing awareness of cervical
screening programme and enhanced risk assessment (RR = 0.87,
95% CI: 0.63 to 1.21).
The trial of McAvoy 1991, which assessed 482 participants,
showed little difference in the uptake of screening betweenwomen
who received printed material as a form of education and those
shown educational videos or slides (RR = 0.86, 95% CI: 0.64 to
1.14).
The trial of Allen 2001, which assessed 2944 participants, showed
no significant difference in the uptake of screening between
women who worked in worksites with workshops aimed at in-
creasing cervical screening led by peer health advisors and those in
the non-intervention group (RR= 1.02, 95% CI: 0.99 to 1.05).
Analysis 6.1
Lay health outreach worker and media education versus
media education alone
In the cluster RCT of Mock 2007, 1005 Vietnamese American
women were randomised into either a lay health worker (LHW)
outreach plus media based education combined intervention or
a media based education only (control). Each LHW used her so-
cial network to recruit 20 women before they were randomised.
Over the program period, 16% of women in the combined in-
tervention group obtained a Pap test (increasing from 65.8% to
81.8%; P < 0.001) compared with 5.4% in the media only group
(increasing from 70.1% to 75.5%; P < 0.001). The increase in
the combined intervention group was significantly greater than
that in the media only group (Z test P = 0.001). Among women
who at baseline had never had a Pap test, 46% of those in the
combined intervention group obtained one during the program
period (P < 0.001) compared with 27% of those in the media only
group (P < 0.001). Again, the increase was significantly greater
in the combined intervention group (Z test P = 0.001). In the
combined intervention group, 21.6% became up-to-date during
the program period (increasing from 45.7% to 67.3%; P < 0.001)
compared with 4.8% in the media only group (increasing from
50.9% to 55.7%; P = 0.035). The increase in being up-to-date
was also significantly greater in the combined intervention group
(Z test P = 0.001) (Analysis 6.2).
14Interventions targeted at women to encourage the uptake of cervical screening (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Standard invitation and printed education versus standard
invitation only
The trial of Eaker 2004, which assessed 12,157 participants, did
not show a significant increase in the uptake of cervical in women
who received both standard invitation and printed education ma-
terial compared to women who received the standard invitation
to attend screening (RR = 1.05, 95% CI: 0.99 to 1.11). Analysis
6.3
12 week cancer screening education versus control
In the cluster RCT of Navarro 1995, 36 lay community work-
ers (consejeras) were recruited and trained to conduct educational
group sessions. Each consejera recruited approximately 14 peers
from the community to participate in the program. The consejeras
were randomly assigned to either a 12 week cancer screening inter-
vention group or a control group. The authors reported although
both groups increased Pap smear use, the increase was higher for
the cancer intervention group than the control group. The differ-
ence approached statistical significance using participants as the
unit of analysis (P = 0.10), but not when consejera was the unit
of analysis (P = 0.37).
Counselling
Counselling versus control
Meta-analysis of two trials (Rimer 1999; Ward 1991), assessing
393 participants, found that women given counselling to encour-
age attendance of a cervical screening programme had a signifi-
cantly higher uptake of screening than those given no counselling
or patient prompts alone (RR = 1.23, 95% CI: 1.04 to 1.45).
The percentage of the variability in effect estimates that is due to
heterogeneity rather than chance is not important (I2 = 0%) (I2 =
0%). Analysis 7.1
Counselling versus other
The trial of Rimer 1999, assessing 208 participants, found little
difference in the uptake of cervical screening between women who
received telephone counselling aimed at increasing awareness of
cervical screening programme and women who received provider
prompts (RR = 1.13, 95% CI: 0.90 to 1.41). Analysis 8.1
Risk Factor Assessment
Enhanced risk assessment versus control
Meta-analysis of two trials (Greene 1999; Kreuter 1996), assessing
145 participants, showed little difference in the uptake of screen-
ing between women who had an enhanced risk assessment and
those in the control group (RR = 1.52, 95% CI: 0.58 to 3.95).
The percentage of the variability in effect estimates that is due
to heterogeneity rather than chance may represent considerable
heterogeneity (I2 = 87%). The results of the two trials differed
markedly where the trial of Greene 1999 showed a statistically sig-
nificant increase in the number of women screened who received
the enhanced risk assessment compared to control (RR = 2.53,
95% CI: 1.42 to 4.51), whereas the Kreuter 1996 trial showed no
significant difference between the two groups (RR = 0.95, 95%
CI: 0.64 to 1.42). Analysis 9.1
Enhanced risk assessment versus other
The trial of Kreuter 1996, which analysed 70 participants, found
no statistically significant difference in the uptake of cervical
screening between women who had an enhanced risk assessment
and women who received a ’typical’ risk assessment (RR = 1.20,
95% CI: 0.79 to 1.81). Analysis 10.1
Procedures
Access to health promotion nurse versus control
The trial of Robson 1989), which assessed 1407 participants,
found a significant increase in uptake of screening in women who
had access to a health prevention nurse compared to those who
did not (RR= 1.18, 95% CI: 1.10 to 1.26). There was substantial
heterogeneity between trials (I2 = 76%). Analysis 11.1
Photocomic book
Photocomic book verus placebo comic book
Only one trial (Risi 2004) assessing 658 participants studied pho-
tocomic book use as a tool to promote cervical screening uptake.
It found no significant difference in the uptake of cervical screen-
ing between women who had been exposed to the photocomic
book aimed at promoting cervical screening uptake comparedwith
women who been exposed to a placebo photocomic book. (RR =
0.96, 95% CI: 0.53 to 1.73). Analysis 12.1
Intensive recruitment
Intensive recruitment attempts versus control
One trial (Oscarsson 2007)with 800participants studied intensive
recruitment. A significant increase in cervical screening uptake was
found in women in the intensive recruitment intervention group
compared with those in the control group (RR = 1.59, 95% CI:
1.24 to 2.06). Analysis 13.1
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Message framing
Only one trial (Rivers 2005) assessed message framing in the up-
take of cervical screening in 441 participants. No significant dif-
ferences in uptake were seen. Loss-framed messages whether pre-
vention or detection phrased and gain-framed detection compared
to loss-framed detection messages both showed a non-significant
decrease in uptake (RR = 0.79, 95% CI 0.48 to 1.30). Gain-
framed messages whether prevention or detection phrased and
gain-framed detection compared to loss-framed prevention mes-
sages both showed a non-significant increase in uptake (RR = 1.07,
95% CI 0.62 to 1.83). Analysis 14.1
Reminders
No trials examining the effects of reminders on cervical screening
uptake were identified.
Economic
No trials with economic outcomes were identified.
Informed uptake of cervical screening
None of the trials identified in this review reported informed con-
sent to cervical screening.
Secondary outcomes
A summary of the data relating to secondary outcomes is presented
in Table 1.
Booking of appointments
One trial (n =273) used the booking of appointments for screening
as an outcome measure (Greene 1999). The trial population was
randomly divided into three groups: usual care (women received
general dietary and health information), cancer education (women
received general information about cervical cancer risk factors and
screening recommendations), and cognitive behavioural interven-
tion (women received feedback about personal risk for cancer and
engaged in a clinical interview to enhance self-efficacy for preventa-
tive behaviour).Women in the usual care groupweremore likely to
schedule an appointment for a Pap smear than those who received
the cognitive behavioural intervention (usual care = 79% versus
cognitive behavioural intervention = 37%, P < 0.0001). Women
in the usual care group were also more likely to attend without
rescheduling the appointment (usual care = 64% versus cognitive
behavioural intervention = 35%, P < 0.001). The booking of ap-
pointments did not differ significantly between the women who
received cancer education and those who received the cognitive
behavioural intervention. It was difficult to assess the quality of
this study as it was only published as an abstract and not further
details were available.
Attitudes to screening
One trial (n = 3094) examined participants attitudes to Pap smear
screening (Byles 1995). The following number of 384 respond-
ing women reported receiving the intervention: invitation letter
154 (72%), invitation letter and behavioural prompts (e.g. prompt
cards) designed to address aspects believed to be associated with
poor screening rates 134 (78%) letter, 100 (58%) card, and 109
(64%) pamphlet; control (not applicable). The following num-
ber of women responders said they had read the material sent: 1.
147 (69%); 2. 128 (75%) letter, 7 (4%) card, 101 (59%) pam-
phlet; control (not applicable). In terms of those women who re-
ceived the invitation letter 118/151 (78%) of the women said that
they were pleased to have the intervention personally addressed
to them, only 1/151 (1%) said they were displeased and the re-
mainder were not sure. In comparison, of those women who re-
ceived the invitation letter andbehavioural prompts 89/132 (68%)
were pleased, 3/132 (2%) were displeased and the remainder were
unsure. 152/155 (98%) of the women who received the invita-
tion letter thought that the intervention should be sent to all
women, 2/155 (1%) did not and the remainder were unsure. 124/
130 (95%) of women who received the invitation letter and be-
havioural prompts thought the intervention should be sent to all
women, 1/130 (1%) did not and the remainder were unsure.
Costs of the interventions
Five trials (n = 7718 participants in total) presented cost data
(Binstock 1997, McDowell 1989, Oscarsson 2007, Stein 2005,
Vogt 2003). The first trial used five different intervention groups
(Binstock 1997). However only those groups that used an inter-
vention aimed at women (and not healthcare providers) were in-
cluded in this review: telephone invitation, invitation letter, and
a control group. The total estimated costs ($US) per interven-
tion group were as follows: telephone invitation $4282, invitation
letter $1918, memo to primary provider $8933, medical record
reminder $1090 and control group (not stated). In terms of the
uptake of screening tests invitation letters produced a greater in-
crease compared with invitation letters or the control group.
The second trial used four different intervention groups, but again
not all of the interventions were aimed solely at women, some
were aimed at healthcare providers (McDowell 1989). The fol-
lowing groups were considered in this review: GP letter invita-
tion, telephone invitation, and control (usual care). The estimated
costs ($US) per additional Pap smear performed as compared with
usual care were: GP invitation letter $14.23, telephone interven-
tion $11.75 (assuming a salary of $60) or $5.88 (assuming a salary
of $30 per hour).
The trial of Stein 2005 used four different intervention groups:
No intervention (Control); telephone intervention; letter from
Health Authority District Cervical Screening Commisioner on
behalf of National Cervical Screening Programme and letter from
awell known journalist and broadcaster. Cost effectiveness analysis
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performed. Average cost per attender was £145.12 for telephone
call, £14.29 for letter from commissioner and £37.14 for letter
from a celebrity.
The trial of Vogt 2003 had examined the costs of each smear
gained in the intervention groups above the cost of a smear in
the control (usual care) group. Cost effectiveness analysis showed
that for each additional Pap smear, the letter/letter intervention
cost $185, the phone/phone intervention cost $305 and the letter/
letter intervention cost $1117 for each additional Pap smear.
Oscarsson 2007 compared intensive recruitment using multi-
ple methods with a control groups. The cost per smear was
66.87EUROand 16.63EURO respectively. Each additional smear
obtained in the trial cost 151.36EURO.
D I S C U S S I O N
Summary of main results
Overall, invitations and educational interventions appeared to be
the most effective methods of increasing the absolute uptake of
cervical screening. However, heterogeneity between the trials lim-
ited the statistical pooling of data. Evidence regarding the effec-
tiveness of other interventions such as economic incentives, pro-
cedural interventions (i.e. revealing the gender of the smear taker
and using a health promotion nurse), counselling and risk factor
assessment was limited by the number of included trials and their
moderate or high risk of bias. Furthermore, statistical pooling of
the data were often limited by the presence of substantial hetero-
geneity between the trials.
Invitations
In general, invitation letters were effective at encouraging women
to attend for a Pap smear. Cervical cancer screening programmes
in theUK, Italy, Sweden and other countries already invite women
to attend via a letter, with or without appointments, as part of their
national call/recall system. However, the use of such systems in
developing countriesmay be difficult to implementwhere issues of
migration, literacy and access to remote areas may be of concern.
There was also some limited evidence that telephone invitations
increased uptake, but it was unclear whether this practice was
more effective than invitation letters. Telephone invitations are
not routinely used in organised screening programmes such as
that in the UK and would be even more difficult to implement
in developing countries where access to telephones may be an
issue. It was also unclear as to whether sending invitation letters
with appointments was any more effective than sending invitation
letters alone. However, there was some evidence to suggest that
invitation letters with fixed appointments weremore effective than
invitations with open appointments.
Current practice in the UK and a number of other countries in-
volves sending invitation letters both from GPs and/or Health
Authorities (NHS Information Centre 2010). The effectiveness
of sending letters from different authority sources was evaluated
in three trials (Bowman 1995; Segnan 1998; Stein 2005). All of
these trials favoured GP/local authority letters over other sources.
It is not possible to say definitively which approach was more ef-
fective, due to the limited evidence from good quality trials. No
trial showed a cost-effectiveness benefit of any alternative invita-
tion method over the standard care (usually a letter). Given the
effectiveness of invitation letters in encouraging uptake and that
no other intervention has been shown to be more cost effective, it
remains appropriate to use existing invitation approaches. It must
be recognised that for this approach to be effective, robust admin-
istrative procedures must be in place and a comprehensive, accu-
rate, up-to-date register maintained.
Education
There was insufficient evidence in the form of statistically signif-
icant findings from good quality trials to support any particular
educational intervention, but overall the consensus from the tri-
als examining educational interventions was in favour of the in-
tervention over the no intervention/usual care control. However,
heterogeneity between the trials limited the statistical pooling of
data. Amongst ethnic minority groups there appeared to be some
limited evidence to support the use of lay members of the com-
munity in presenting culturally-tailored information, particularly
when performed “face-to-face”. This may be of relevance in devel-
oping countries where remote areas and literacy may be an issue.
However, the findings may vary according to ethnic group and
further research is required.
Educational materials are likely to be important in increasing in-
formed uptake, providing they cover all aspects of the screen-
ing process. For example, the Department of Health in the UK
has produced a leaflet emphasising the risks and benefits and this
should be included with every invitation for screening (NHS CSP
2009). No trials have attempted to measure the effectiveness of
interventions at increasing the informed uptake of Pap smears.
Intensive recruitment attempts
Although only examined in a single trial, intensive recruitment
techniques, including telephone interviews, letters and other pro-
motive efforts showed a promising increase in uptake. However,
the cost per extra smear gained (151.36EURO) may limit the
wider application of this approach.
Overall completeness and applicability of
evidence
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Future intervention trials should aim to minimise barriers to up-
take amongst those who choose screening, based on a full under-
standing of the likely benefits, limitations and potential harm. Tri-
als should include a measure of knowledge and whether the infor-
mation provided is used in the decision making process. Just as an
intervention to increase uptake may be ineffective, an intervention
to increase informed uptake might also be ineffective. For exam-
ple, it should not be assumed that giving a leaflet on the risks and
benefits of screening will necessarily increase informed uptake. It
may be that some interventions, which are effective for increasing
uptake (such as appointments), are not effective at increasing in-
formed uptake, and the opposite may also be true. Similarly in-
terventions which are effective in developed countries may not be
as effective in developing countries or may present problems in
terms of their implementation. At present the evidence regarding
the effectiveness of interventions is dominated by studies set in de-
veloped countries and there is a need for research which is likely to
be more applicable to developing nations. Future trials should also
consider ongoing changes in screening technology. As new screen-
ing tests become available their potential effects on participation
levels in cervical screening programmes should be considered. At
present randomised controlled trials are underway to assess the
effectiveness of HPV testing and its likely role in the UK cervical
screening programme. However, it has been suggested that the in-
troduction of this test may adversely effect the screening uptake
rates because of the connotation of sexual promiscuity attached to
a positive HPV test/abnormal Pap smear.
Research into screening uptake including the uptake of Pap smears
is still expandingwith new studies being published each year.How-
ever, at present there is very little research relevant to developing
countries and it is difficult to state with any degree of certainty
how effective the interventions discussed in this review will be in
such settings.
Quality of the evidence
The review and the findings of the review are very much depen-
dent on the validity and quality of the 38 trials reported. The risk
of bias of the individual trials included in the review was assessed
independently by two review authors using pre-defined checklists.
Although a number of the trials were of reasonable quality and
only at moderate risk of bias, a number of remaining trials suffered
from methodological problems and inadequate reporting. With
regards to the latter attempts were made to contact authors to clar-
ify various points, but replies were not received in a number of
trials. Of note, several trials would have been eligible if proper ran-
domisation procedures had been followed rather than using quasi-
randomisation techniques. A number of trials randomised women
without first assessing their eligibility so leading to the exclusion
of large numbers of women post-randomisation. Many trials also
failed to use appropriate analyses such as intention to intervene
analyses and the appropriate consideration of the effects of clus-
tering in cluster randomised trials. By not adequately accounting
for the potential effects of clustering data from a number of trials
it was not available for inclusion in the summary of relative risk
values.
Even though risk ratios were calculated in most of the RCTs in-
cluded in this review, the pooling of data was restricted because
of clinical heterogeneity. Of the meta-analyses that could be per-
formed there was quite often substantial statistical heterogeneity
present. The conclusions and implications for practice are primar-
ily based on those interventions for which there was evidence from
several RCTs, i.e. invitations and educational materials. However,
issues of heterogeneity and study quality should be borne in mind
when interpreting these findings. A number of trials looked at
other interventions but these were often either limited in number,
were of questionable validity or both. To increase informed up-
take, future interventions should include information on the likely
harms and risks, as well as the benefits of screening. These trials
should include a measure of knowledge and whether this knowl-
edge was used in the decision to undergo screening. Furthermore,
more trials are needed which target ethnic minority groups and
other groups where uptake is low.
Potential biases in the review process
The comprehensive search strategy used in the review is likely
to have located most of the published trials and our thorough
search of the grey literature meant that every attempt had been
made to obtain data from unpublished trials. Decisions on the
relevance of trials were made by two reviewers in a two stage sifting
process. Titles and abstracts of the search results were initially
searched, then full articles were sifted of potentially relevant papers
identified from the initial sift. In cases of disagreement, a third
reviewer was called to decide on disputed trials. We restricted the
included studies to RCTs as they provide the strongest level of
evidence available.We excluded quasi-randomised trials and other
non-RCTs, hence we have attempted to reduce bias in the review
process.
The greatest threat to the validity of the review is likely to be the
possibility of publication bias i.e. studies that did not find the
treatment to have been effective may not have been published.
We were unable to assess this possibility for most outcomes as
most comparisons of the interventions were restricted to either a
meta analysis of only a low number of trials or single trial analyses.
However, the analysis of invitations versus control did not suggest
that publication bias was likely to be a problem. It is acknowledged
that although abstracts, full articles and unpublished reports were
found (through contacting experts in the field and searching the
grey literature and reference lists), some may have been missed,
but this risk of publication bias is likely to be minimal.
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Agreements and disagreements with other
studies or reviews
A meta-analysis performed by Tseng 2001 showed that women
who received a reminder letter to attend for cervical screening were
significantly more likely to attend (OR = 1.64, 95% CI: 1.49 to
1.80) than those who received no intervention. This is in agree-
ment with the findings of this Cochrane review. A meta-analysis
by Yabroff 2003 agrees with the findings of this review that let-
ter reminders and telephone reminders are effective at increasing
cervical screening uptake. The findings of this review are also in
agreement with the conclusion of Yabroff 2003 that media inter-
ventions do not lead to increased Papanicolou smear use and the
finding that peer or lay health worker interventions may have a
marginal, though not statistically significant benefit.However, this
review is not in agreement with their conclusion that “telephone
reminder was associated with the largest increase in Papanicolou
smear use”. Whilst this review shows telephone reminders to be
effective, reminder letters with a fixed appointment appeared to
be more so.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There was sufficient evidence from good quality RCTs to support
the use of invitation letters in increasing the uptake of Pap smears.
There was also some evidence to suggest that educational inter-
ventions may increase Pap smear uptake. Overall, educational ma-
terials appeared promising, but it is unclear without evidence from
additional good quality RCTs which methods (i.e. printed, video/
slide or face to face presentations) are most effective. A number
of other interventions including revealing the gender of the smear
taker and using a health promotion nurse appeared to be promis-
ing approaches, but their effectiveness was only examined in a lim-
ited number of trials. Likewise interventions by lay health workers
appear to be promising in improving uptake, although the number
of trials in this area is limited. There was no evidence on which
to base implications for practice regarding the informed uptake
of cervical screening. Overall, these findings relate to screening in
developed countries and their relevance to developing countries is
unclear.
Implications for research
The following implications are likely to be relevant to screening
in developed countries:
1. Invitations and educational materials appear to be effective
at increasing uptake of cervical cancer screening. Further research
into the relative effectiveness and cost effectiveness of these
interventions would help to inform decision-making. In
particular it is unclear which types of educational intervention
are the most effective.
2. Further research is required to determine the effectiveness
of promising interventions such as revealing in an invitation
letter the gender of the smear taker, using a health promotion
nurse, the use of lay outreach health workers and intensive
attempts at recruitment.
3. When designing and reporting future trials researchers
should pay particular attention to the following issues: the use of
an adequate method of randomisation, the blinding of those
assessing study outcome measures, adequate concealment of
treatment allocation, adequate follow-up of all participants
included in the initial randomisation process, selective reporting
of outcomes, and the use of appropriate analyses, particularly in
the case of cluster RCTs. Researchers should also try to ensure
the enrolment of adequate numbers of eligible participants and
interventions should be reported in sufficient detail.
4. A group of women who attend for smears that are
particularly at risk are those with inadequate or abnormal smears.
Further research should examine the effectiveness of various
methods to ensure adequate attendance at follow up for
abnormal smears.
5. A concentrated effort should be made to conduct good
quality trials in developing countries. In these areas, there is
usually no national screening programme, cervical screening is
often non-existent and Pap smear or liquid based cytology are
not practical. In such situations, other screening modalities such
as visual inspection with acetic acid have been shown to
acceptable, feasible and safe (Sankaranarayanan 2004) and
should be considered.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Adab 2003
Methods Design - RCT
Baseline comparability - Significantly higher proportion of non-white women in the
intervention group. Otherwise no significant differences between study groups
Follow-up - Nil.
Participants Country - UK
Setting - 3 general practices in Birmingham
Initial screening status - Any
300 women attending their GP practice.
Inclusion criteria - aged 20 to 64 years;
Exclusion criteria - Incomplete questionnaire
Interventions 1. Control leaflet based on that produced by National Health Service Cervical Screening
Programme, though with references to “cervical” cancer, “cervical” screening or “smear
test” removed
2. Intervention leaflet. As above with additional information on average individual risk
of cervical cancer, possibility of false positive/negative results, uncertainties attached to
screening process, the absolute benefit associated with the screening and the cost of the
process to the NHS
Outcomes Self-reporting of “willingness to have study screening test.”
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Computer generated list of random num-
bers”
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Participants were blinded. It is unclear if
outcome assessors were blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk % analysed: 91% (274/300)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
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Adab 2003 (Continued)
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
Allen 2001
Methods Design - Cluster RCT
Baseline comparability - no significant differences between study groups
Follow-up - 3 years.
Participants Country - US
Setting - Workplace
Inclusion criteria - aged 50 years or older
Interventions 1. Workplace at worksites led by trained peer health advisors n = 1512
2. No workshops n=1431
Outcomes Pap smear uptake - self-reported
Notes Intervention lasted 16 months. Non-intervention group were provided with skills and
resources to replicate intervention program
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
High risk % analysed: 66% (2795/4253)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
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Binstock 1997
Methods Design - RCT
Baseline comparability - no significant differences between study groups
Follow-up - 1year
Participants Country - USA
Setting - HMO
Initial screening status - overdue
Eligible participants were identified from the medical records of the Kaiser Permanente
Health Plan, South California Region (HMO). Half of those eligible (n = 7630) were
included in the final analysis
Inclusion criteria - aged 25 to 49 years; enrolled in HMO for at least 3 years; likely to
seek outpatient care at one of the three medical centres
Exclusion criteria - Pap smear within the last 3 years
Interventions 1. Telephone call n = 1526
2. Letter n = 1526
3. Memo to woman’s primary provider n = 1526
4. Chart reminder affixed to outside of woman’s medical record n = 1526
5. Control group n = 1526
Outcomes Pap smear uptake and costs determined by administrative records
Notes No details were provided as to the selection criteria for half of the women who were
entered into the study
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk % analysed: 7630/7630 (100%)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
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Bowman 1995
Methods Design - RCT
Baseline comparability - no significant differences between study groups
Follow-up - 6 months
Participants Country - Australia
Setting - General practice
Initial screening status - overdue
Over 7000 potentially eligible women in an Australian community were identified by a
random household survey (developed by the Australian Bureau of Statistics)
Inclusion criteria - aged 18 to 70 years
Exclusion criteria - not sexually active; could not speak English; infirm; not at home
when contacted; hysterectomy
Interventions 1. GP reminder letter n = 255
2. Women’s health clinic invitation n = 220
3. Pamphlet n = 219
4. Control group (not stated) n = 219
Outcomes Pap smear uptake determined by administrative records
Notes Comparison of self-reported uptake and administrative records of uptake indicated that
women were very accurate in their self-report of screening when it had actually taken
place, but inaccurate in almost a quarter of instances when they stated that it had occurred
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Low risk “Interviewers were unaware of which group
in the study women had been assigned to”
Incomplete outcome data (attrition bias)
All outcomes
High risk % analysed: 659/913 (72%)
GP reminder letter: 178/255 (70%)
womenwere analysed (“Thirty-five women
initially assigned to this group were ex-
cluded because of the non-participation of
their GPs”).
Women’s health clinic invitation: 164/220
(75%) women were analysed
Pamphlet: 162/219 (74%) women were
analysed
Control group: 155/219 (71%) women
were analysed
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Bowman 1995 (Continued)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
Buehler 1997
Methods Design - RCT
Baseline comparability - no significant differences between study groups
Follow-up - 2 months and 6 months
Participants Country - Canada
Setting - Family medicine clinic
Initial screening status - due
Random sample of 441 women listed as patients of two clinics (one urban and one rural)
affiliated with the Memorial University of Newfoundland
Inclusion criteria - 18 to 69 years
Exclusion criteria - Pap smear in past 3 years; hysterectomy; moved or had records with
clerical errors
Interventions 1. Personal letter and reminder letter 4 weeks later n = 221
2. Control group received no letter n = 220
Outcomes Pap smear uptake determined by administrative records
Notes Sample size calculations did not take into account the lag time between taking tests and
registering tests, which could and did cause the loss of participants
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Of the 1302 ... eligible women, we ran-
domly selected
650 using computer-generated numbers”.
From the CONSORT flow diagram it ap-
pears that the 441 women participating in
the trial after exclusions were randomised
in a similar way
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
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Buehler 1997 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk % analysed: 88% (386/441)
By treatment arm:
Personal letter and reminder letter: 178/
221 (81%)
Control: 208/220 (95%)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
Burack 1998
Methods Design - RCT
Baseline comparability - no significant differences between study groups
Follow-up - 1 year
Before randomisation women were excluded if their last smear was abnormal/insufficient
for cytology (n = 4708); 140 were excluded from the patient reminder intervention as
they discontinued HMOmembership; 2055 were excluded from the physician reminder
intervention as they did not attend their physician
Participants Country - USA
Setting - HMO
Initial screening status - due
Women were recruited from five HMO sites enrolled in year 1. Only three of these sites
enrolled in year 2. 5801 women were randomised to physician reminder/no reminder.
During a second later round of randomisation (patient reminder vs no reminder) further
women were excluded
Inclusion criteria - at least 40 years old; HMO member; visited one of the primary care
study sites in Detroit, Michigan, USA
Exclusion criteria - previous abnormal or insufficient Pap smear
Interventions 1. An invitation letter reminding women that they were due for a Pap smear (964
analysed)
2. Reminders for both physician and participants (960 analysed)
3. Reminders for the physicians (960 analysed)
4. Control (no reminder to either physicians or participants (964 analysed)
5801 women were randomised but only gives breakdown of women analysed by treat-
ment arm
Outcomes Pap smear uptake determined by administrative records
Notes Unclear methodology. Two stage randomisation and large numbers of exclusions after
first randomisation. Not clear how many women were originally randomised to each of
the four study groups
Risk of bias
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Burack 1998 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “A two-stage randomization procedure was
used ... At the beginning of the study pe-
riod, the 5801 women ... were randomly
assigned using a site specific, stratified ran-
domization procedure to receive or not re-
ceive the physician reminder intervention.
Strata were defined by age, previous Pap
smear use, and number of HMO visits
in the preceding year. To avoid overload-
ing the clinics, a separate randomization
was carried out to assign women to pa-
tient reminder intervention. Women who
remained eligible were selected and ran-
domized to patient reminder intervention
on a weekly basis in groups of 156”
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
High risk % analysed: 66% (3848/5801)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
Burack 2003
Methods Design - Cluster RCT
Baseline comparability - no significant differences between study groups
Follow-up - 1 year
Participants Country - US, Detroit.
Setting - HMO
Initial screening status - due
Inclusion criteria - aged 40 years or older and had visited a primary car provider at one
of the study sites during the two years preceding the intervention period
Exclusion criteria - not reported
Interventions Cluster RCT
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Burack 2003 (Continued)
Outcomes 1. Sent reminders for Pap smear and mammogram n = 1243
2. Sent reminders for mammogram only n = 1228
Notes Pap smear uptake ? from study site records
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk % analysed: 100% (2471/2471)
However, loss of participantswhomayhave
moved out of area, not received reminder
etc is not clear
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
Byles 1994
Methods Design - RCT (cluster)
Baseline comparability - study regions matched on census data
Follow-up - 3 months (TV media and letter), 6 months (GP intervention)
Participants Country - Australia
Setting - Community
Initial screening status - due and overdue
Nine geographically discrete, regionswere selectedwithin three adjacentTVbroadcasting
areas. The regions were randomly assigned to the study groups and data gathered on
eligible women through administrative records pre-and post-intervention
Inclusion criteria - aged 18 to 70 years; English-speaking
Exclusion criteria - physically/intellectually impaired
Interventions 1. TV media campaign n = n/a
2. TV media combined with invitation letter n = n/a
3. TV media combined with GP based recruitment through workshops n=n/a
4. Control n = n/a
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Byles 1994 (Continued)
n/a not applicable as data was gathered from administrative records for the regions giving
overall Pap smear attendances during the pre- and post- intervention periods
In the letter intervention group using information gathered from electoral registers (reg-
istration was mandatory) all eligible women were sent a letter
Outcomes Pap smear uptake determined by administrative records
Notes Analysis limited by the 3 and 6 month post-intervention follow-up periods, a longer
period was prevented by contamination by a state-wide media campaign. Differential
effects of interventions on outcome for the different regions may reflect different baseline
screening rates that could not be assessed during matching. Unit of allocation different
from unit of analysis and no appropriate account was taken of this is the analysis
1. TV media campaign n = n/a
2. TV media combined with invitation letter n = n/a
3. TV media combined with GP based recruitment through workshops n=n/a
4. Control n = n/a
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
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Byles 1995
Methods Design - RCT (cluster)
Baseline comparability - study regions were matched as closely as possible using census
data
Follow-up - 3 months
28% of the letter intervention group did not recall ever receiving the intervention; not
clear how many women were followed-up
Participants Country - Australia
Setting - Community
Initial screening status - due
Three geographically separate postal regions were randomly allocated to different inter-
ventions. Data on eligible women within the regions was gathered via administrative
records pre- and post-intervention
Inclusion criteria - aged 18 to 70 years; no Pap smear in previous 3 years; Australian or
British citizenship
Exclusion criteria - not stated
Interventions 1. Personally addressed letter with simple information about Pap smears n = ? (959
analysed) (99 attended for screening)
2. Personally addressed letter combined with a series of targeted behavioural prompts (e.
g. prompt cards) designed to address aspects believed to be associated with poor screening
rates n = ? (933 analysed) (95 attended for screening)
3. Control n = ? (1202 analysed) (97 attended for screening)
Outcomes Pap smear uptake determined by administrative records
Notes Timescale of the intervention was not stated and the 3 month follow-up period was
short and may have limited the results. Unit of allocation different from unit of analysis
and no appropriate account was taken of this in the analysis. Unclear how many women
were followed-up
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
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Byles 1995 (Continued)
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
Byles 1996
Methods Design - RCT (cluster)
Baseline comparability - regions were matched as closely as possible using census data
Follow-up - 3months
A 15% adjustment of the denominator was made to account for the estimated hysterec-
tomy rate
Participants Country - Australia
Setting - Community
Initial screening status - due and overdue
Nine geographically distinct postal regions were randomly allocated to one of the inter-
vention groups. Data about the women within the regions were gathered pre- and post-
intervention using administrative records
Inclusion criteria - aged 18 to 70 years; no Pap smear in the previous 3 years
Exclusion criteria - not stated
Interventions 1. Personalised letter advising women to attend screening and providing simple infor-
mation Followed up by a second mailing campaign 3 years later n = ? (? analysed)
2. No letter in the first mailing but letter sent during second mailing 3years later n = ?
(? analysed)
3. Control, no letter on either occasion n = ? (? analysed)
Outcomes Pap smear uptake determined by administrative records
Notes Previous campaigns may have had an unknown influence on the current campaign. The
iterative process used to provide estimates of expected and observed may be affected
by the limited follow-up period, questioning the reliability of the analysis. Participants
were only partially randomised (to initial letter). Unit of allocation different from unit
of analysis and no appropriate account taken of this in the analysis
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
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Byles 1996 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
Clementz 1990
Methods Design - RCT
Baseline comparability - no differences in any of the variables examined
Follow-up - 4 months
Participants Country - USA
Setting - University family medicine clinic
Initial screening status - due
220 female patients attending ambulatory clinic
Inclusion criteria - aged 50 to 69 years
Exclusion criteria - symptomatic for cervical cancer; previously had cancer
Interventions 1. Personalised GPs letter, one month before due date of tests with an educational
component n = 116
2. Control group received usual care (not described) n = 104
Outcomes Pap smear uptake determined by administrative records
Notes Authors offered no explanation as to why the recall intervention had an adverse effect on
people attending cervical screening, i.e. why such an intervention would make people
less likely to attend. The low power of the study was attributed to imbalances between
the intervention and control groups. There was an additional imbalance as a result of
excluding patients post-randomisation
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Patients were then assigned by a com-
puter-generated random number to two
groups”
Allocation concealment (selection bias) High risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk “The physicians remained blinded to the
individual patient’s status throughout the
study”. However it was unclear whether or
39Interventions targeted at women to encourage the uptake of cervical screening (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Clementz 1990 (Continued)
not the outcome assessors were blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk % analysed: 178/220 (81%)
By treatment arms:
Personalised GPs letter: 102/116 (88%)
Control: 76/104 (73%)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
Del Mar 1998
Methods Design - RCT
Baseline comparability - no differences in age and postcode area
Follow-up - 1 year
Participants Country - Australia
Setting - Community
Initial screening status - due and overdue
689 women on the electoral roll in South Brisbane
Inclusion criteria - aged 18 to 67 years; Vietnamese
Exclusion criteria - not stated
Interventions Media campaign on cervical screening introduced for whole region 2 months before
letters sent
1. Personal letter (in Vietnamese) informing them about screening and its benefits n =
359
2. Control group did not receive a letter n = 330
Outcomes Pap smear uptake determined by administrative records
Notes Women in both groups were drawn from the Vietnamese community resident in one
area, so there is a possibility of contamination
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
Low risk “After each pathology service had supplied
the dates and results for each woman, the
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Del Mar 1998 (Continued)
All outcomes dataset was stripped of
its fields of names and dates of birth, and
the order changed randomly so that no in-
dividual woman’s results could be identi-
fied. This file was then analysed”
Incomplete outcome data (attrition bias)
All outcomes
Low risk % analysed: 689/689 (100%)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
Eaker 2004
Methods Design - RCT
Baseline comparability - no significant differences between study groups
Follow-up - 5months
Participants Country - Sweden
Setting - Uppsala county, Sweden
Initial screening status ? Due
Inclusion criteria - aged 25 to 59 years, no Pap smear within past 3 years
Exclusion criteria - had asked to be excluded from call-recall system
Interventions 1. Standard invitation n = 6140
2. Modified invitation n = 6100
Outcomes Pap smear uptake determined by national register
Notes Study includesmultiple sequential randomised interventions. In viewof sequential effects
on subsequent interventions only primary intervention included in forest plot
Other interventions were reminder letter versus no reminder to women who had not had
smear at 5 months and then phone reminder versus no phone reminder at 2 months to
women who had still not had smear flowing reminder letter. Total follow up for whole
study 12 months
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Low risk “Collaborators in the study were blinded to
the women’s group assignment.”
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Eaker 2004 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk However “Becasue the end-point was
whether a woman had a Pap smear or not,
none of the collaborators, except the re-
search assistants conducting the phone re-
minder, could influence the decision.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk % analysed: 99% (12,157/12,240)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
Greene 1999
Methods Design - RCT
Baseline comparability - not stated
Follow-up - 6 months
Participants Country - USA
Setting - Rural primary care in low income, minority population
Initial screening status - due
273 women presenting for outpatient care who did not have a Pap test during the
preceding year
Inclusion criteria - not stated
Exclusion criteria - not stated
Interventions Based on Social Cognitive Theory and Motivational Interviewing Methods
1. Usual care n = 79 (? analysed) received general dietary and health information
2. Cancer education n = 97 (? analysed) received general information about cervical
cancer risk factors and screening recommendations
3. Cognitive behavioral intervention n = 97 (? analysed) received feedback about personal
risk for cancer and engaged in a clinical interview to enhance self-efficacy for preventative
behaviour
Outcomes Pap smear uptake and booking of appointments determined by administrative records
Notes Standard clinical procedures to advocate for and provide Pap tests were not withheld
from any of the participants; all study participants received attention in addition to usual
preventative care
Risk of bias
Bias Authors’ judgement Support for judgement
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Greene 1999 (Continued)
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
Hunt 1998
Methods Design - RCT
Baseline comparability - no significant differences between the study groups in terms the
factors investigated
Follow-up - 3 months
97/119 (81.5%) of women in the personal approach group and 37/125 (30%) of in the
letter group were not contacted. These women were included in the final analysis
Participants Country - Australia
Setting - Community
Initial screening status - overdue
372 women identified from files at a women’s clinic staffed by Aboriginal health workers
in Danila Bilba
Inclusion criteria - resident in the Darwin area; overdue for screening
Exclusion criteria - not stated
Interventions 1. Personal approach. Women approached by Aboriginal health workers and invited for
screening (119 analysed)
2. Letter. Designed by Aboriginal workers stating individual overdue for smear and
inviting them to attend (125 analysed)
3. Control. Usual care with reminder tags for clinic staff attached to medical records
(122 analysed)
372 women were randomised but only gives breakdown of women analysed by treatment
arm
Outcomes Pap smear uptake determined by administrative records
Notes Women were included in the final analysis even though in many cases, particularly in
the personal approach group, they had not received the intervention. The 3mth follow-
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Hunt 1998 (Continued)
up period is relatively short
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Women were randomly allocated to one
of three groups by matching a list of the
women’s file numbers to a list of com-
puter-generated random numbers desig-
nating the group number (1, 2 or 3)”
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Low risk “The person reviewing the files (JH) was
not aware
of the women’s group allocation, and was
not involved in sending letters or con-
tacting women in the personal approach
group”
Incomplete outcome data (attrition bias)
All outcomes
Low risk % analysed: 98% (366/372)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
Kreuter 1996
Methods Design - RCT
Baseline comparability - no significant differences between the study groups in terms of
demographic variables
Follow-up - 6 months
186/1317 failed to complete the 6mth follow-up questionnaire; 457/1131 were not
considered to be at risk or did not want to change and so were not included in the final
analysis
Participants Country - USA
Setting - Family medical practice
Initial screening status - unclear
1317 adult patients from eight family medical practices in North Carolina, USA
Inclusion criteria - aged 18 to 75 years; completed baseline survey
Exclusion criteria - not stated
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Kreuter 1996 (Continued)
Interventions Based on Health Belief Model
1. Typical HRA-computerised assessment of participants’ health risks and provision of
individualised feedback as to their calculated mortality risks n = 427
2. Enhanced HRA-as previous but also assesses benefits, barriers and other psychosocial
factors influencing the individuals’ health related behaviour in order to provide individ-
ualised feedback designed to facilitate self change in health behaviours n = 427
3. Control-no feedback given to participants n = 463
Outcomes Pap smear uptake determined by self report via questionnaire
Notes Also mentions the Precaution Adaption Model. Absolute values for the original number
of individuals eligible to receive the tests at baseline not stated
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
High risk % analysed: 126/1317 (10%)
By treatment arm:
Typical HRA-computerised assessment:
46/427 (11%)
Enhanced HRA: 48/427 (11%)
Control: 32/463 (7%)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
Lancaster 1992
Methods Design - RCT
Baseline comparability - no significant differences between study groups in terms of
mean age
Follow-up - not stated
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Lancaster 1992 (Continued)
Participants Country - UK
Setting - General practice
Initial screening status - due
2131 women registered with general practices in North Manchester
Inclusion criteria - aged 50 to 64 years; resident in study area
Exclusion criteria - hysterectomy
Interventions 1. Cervical screening invitation sent with breast screening invitation n = 965
2. Breast screening invitation only sent (control) n = 947
Outcomes Pap smear uptake determined by administrative records
Notes Eligibility criteria for participation in the study and for breast and cervical screening
were not explicit. Ineligible women were included in the initial randomisation
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk % analysed: 1794/1912 (94%)
By treatment arm:
Cervical screening invitation: 908/965
(94%)
Control: 886/947 (94%)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
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McAvoy 1991
Methods Design - RCT
Baseline comparability - not stated
Follow-up - 2 months and 4 months
The overall response and consent rate was 73%
Participants Country - UK
Setting - National screening programme
Initial screening status - overdue
737 randomly selected women from the Asian community in Leicester
Inclusion criteria - resident of Leicester; aged 18 to 52 years; not recorded as having had
a smear test
Exclusion criteria - not stated
Interventions 1. Home visit and a multilingual video n = 263
2. Home visit, multilingual leaflet and fact sheet n = 219
3. Posted multilingual leaflet and fact sheet n = 131
4. Control group received no intervention n = 124
Outcomes Pap smear uptake determined by administrative records
Notes Sample may not be representative of the general population as it uses only Asian partici-
pants and originates from a previous study on use of health services. The sample had an
over- representation of Moslems
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The study appears to have used a min-
imisation technique, where an attempt was
made to minimise the imbalance between
the number of patients in each treatment
group over a number of factors; “The final
sample was stratified by age, religion, post-
code area, and by participation in the pre-
vious study (either as respondents or non-
respondents) and then divided into four
groups”
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk % analysed: 737/737 (100%)
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McAvoy 1991 (Continued)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
McDowell 1989
Methods Design - RCT
Baseline comparability - no significant differences between study groups in terms of
marital status and age
Follow-up - 1 year
447/2034 women who were not due for screening were excluded pre-randomisation
Participants Country - Canada
Setting - Hospital
Initial screening status - due and overdue
2034 female patients attending a hospital-based family medical center in Ottawa
Inclusion criteria - aged 18 to 35 years; no previous smear in past year
Exclusion criteria - not stated
Interventions 1. GP letter and reminder letter after 21 days n = 367
2. Physician reminder n = 332
3. Telephone call n = 377
4. Control group n = 330
Outcomes Pap smear uptake and costs determined by administrative records
Notes Study also incorporated 628/2034 women whowere assigned to a practice control group,
but these women were not randomly assigned. By not assessing the eligibility of women
(ie whether they had a smear in the preceding year) a number of women were excluded
from the study post- randomisation
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk % analysed: 100% (1406/1406)
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McDowell 1989 (Continued)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
Mock 2007
Methods Design - Cluster RCT
Baseline comparability - No significant differences between study groups
Follow-up - “3 to 4 months”.
Participants Country - US, Santa Clara County, California
Setting - Vietnamese-American community
Initial screening status - due
Inclusion criteria - aged 18 years or older living in Santa Clara county, California
Exclusion criteria - Not reported
Interventions 1. Lay health worker intervention involving presentations about cervical cancer, question
and answer sessions, and regular contact with participants to explain and access to and
scheduling of appointments. Also had media intervention (n = 491).
2. Media intervention only. Television, radio and print advertisements targeted at the
Vietnamese-American female population (n = 477)
Outcomes Pap smear uptake - self-reported post-intervention questionnaire
Notes Women selected from the social networks of the lay health outreachworkers and therefore
may be more motivated to comply
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk % analysed: 96.3% (968/1005)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
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Mock 2007 (Continued)
Other bias High risk Women selected from the social networks
of the lay health outreach workers and
therefore may be more motivated to com-
ply
Morrell 2005
Methods Design - RCT
Baseline comparability - not reported
Follow-up - 90 days
Participants Country - Australia
Setting - Community
Initial screening status - due
90, 000 women who had not had a Pap smear for ≥ 48months
Inclusion criteria - age 20 to 69 years, not had smear in past 48 months, on New South
Wales Pap Test Register
Exclusion criteria - not stated
Interventions 1. No intervention
2. Letter identical to that usually sent out to women at 27 months after latest Pap smear
or letter giving a similar message, but phrased in a tone more sympathetic to other factors
going on in the woman’s life that might have stopped her from having the test to date
Outcomes Pap smear as recorded on New South Wales Pap Test Register
Notes Both letter styles were analysed together
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk % analysed: 99% (89,699/90,247)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
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Morrell 2005 (Continued)
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
Navarro 1995
Methods Design - RCT (cluster)
Baseline comparability - only one statistically significant difference found, the propor-
tion of women who were employed (17.5% control versus 8.9% intervention), but not
regarded as a threat to internal validity
Follow-up - 6 months
Outcome measure - self-report via interview
Participants Country - USA
Setting - Community
Initial screening status - unclear
500 Latinas in groups of 10 to 15 were recruited through ’consejeras’ (traditional lay
health workers in the Latino community) and randomly assigned according to their
consejeras to either the intervention or control
Inclusion criteria - not stated
Exclusion criteria - not stated
Interventions Based on Cognitive Social Learning Theory
1. Por La Vida (PLV) programme with consejeras (n = 18) taking 12 weekly educational
sessions with the groups of women n = 274
2. Control, no PLV programme instead consejeras (n = 18) participated in a ’Community
Living Skills’ program n = 238
Outcomes Pap smear uptake determined by self-report via interview
Notes The generalisability may be limited as the study focuses on US Latinas of low socio-
economic status who have a low level of acculturation. The differences between the
control (Community Living Skills) and intervention (PLV) programmes were not very
clear. Unit of allocation different from unit of analysis but appropriate analysis using
clusters not individuals was performed.The results were presented using both the women
and the Consejera as the units of analysis. The authors state that the results were limited
as the test completion rates for both the pre- and post-test are lower than desired
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
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Navarro 1995 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
High risk % analysed: 71% (361/512)
PLV programme: 199/274 (73%)
Control: 162/238 (68%)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
Ornstein 1991
Methods Design - RCT (cluster)
Baseline comparability - study groups differed significantly (P = 0.0001) in terms of race,
type of insurance and visit frequency
Follow-up - 1 year
818/3833 in the letter intervention groups (letter only; letter + physician reminder) did
not receive the letters
Participants Country - USA
Setting - Family medicine clinic
Initial screening status - due
7,397 participants and 49 physicians from a university-based medical centre participated
in the study
Inclusion criteria - aged 18 years and over; not screened in previous 2 years; ’active’
patient of the family medicine centre (ie had visited clinic in previous 2 years)
Exclusion criteria - not stated
Interventions 1. Physicians received computerised reminders n = 1988 participants, 14 physicians
2. Participants were sent an invitation to attend followed by another personalised re-
minder letter (6 months later) n = 1925 participants, 12 physicians
3. Both physician and participant reminders n = 1908 participants, 13 physicians
4. Control group, no intervention n = 1576 participants, 10 physicians
Outcomes Pap smear uptake determined by administrative records
Notes A number of biases were reported. The study was limited to analyses of attending partic-
ipants; physicians in the 4 groups were in the same building (blinding was not possible
and the Hawthorne effect may have contributed to some of the improvements); there
were baseline differences in participant characteristics; the unit of allocation (practice
group) was different from unit of analysis (participant)
Risk of bias
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Ornstein 1991 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk % analysed: 100% (7397/7397)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
Oscarsson 2007
Methods Design - RCT
Baseline comparability - not reported
Follow-up - 1year
Participants Country - Sweden
Setting - Community
Initial screening status - Unclear
800 women selected at random
Inclusion criteria - aged 28 to 65 years, resident in Kalmar County, Sweden, no registered
cervical smear during the last 5 years.
Exclusion criteria - not stated
Interventions 1. Control. No intervention. n = 400
2. Intervention included invitation letters, telephone interviews and promotive efforts
for having a cervical smear taken. n = 400
Outcomes Pap smear uptake taken from National Populaition Register
Notes Cost of extra Pap smear gained was calculated 151.36EURO. Smears cost 66.87EURO
each in the intervention group and 16.63EURO in the control group
Risk of bias
Bias Authors’ judgement Support for judgement
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Oscarsson 2007 (Continued)
Random sequence generation (selection
bias)
Low risk “A computer randomly selected 400
women to serve as a study group and an-
other 400 women to serve as a control
group.”
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk % analysed:100% (800/800)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
Pierce 1989
Methods Design - RCT
Baseline comparability - no significant differences were identified between the study
groups for any of the characteristics examined
Follow-up - 1 year
27% (38/142) of women in tagged group did not receive the intervention as they did
not consult their doctor during the study period. 61 women were removed from practice
list during the study: screening group (n = 24), tagged notes group (n = 20), control
group (n = 17), n = 3 died and n = 58 left the practices
Participants Country - UK
Setting - General practice
Initial screening status - due
146/1232 women registered with a general practice
Inclusion criteria - eligible for a smear test
Exclusion criteria - smear in past 5 years; hysterectomy; already on call-recall list
Interventions 1. Letter asking women to have a smear n = 140
2. Physician reminder n = 142
3. Control group n = 134
Outcomes Pap smear uptake determined by administrative records
Notes
Risk of bias
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Pierce 1989 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk % analysed: 100% (416/416)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
Pritchard 1995
Methods Design - RCT
Baseline comparability - no statistically significant differences between study groups and
all women who attended the practice during the study period for age, country of birth,
marital status and education
Follow-up - 1 year
22 women in the intervention groups had hysterectomies but were retained in the anal-
yses; 60% of women in the tagged notes group did not receive the intervention
Participants Country - Australia
Setting - General practice
Initial screening status - due
757/2139 women at a university general practice in a socio-economically disadvantaged
area of Perth
Inclusion criteria - women aged 36 to 69 years
Exclusion criteria - Pap smear in past 2 years; hysterectomy; no attendance at practice
for 3 years or more; known to attend another practice; terminally ill
Interventions 1. Physician reminder (tagged notes) group n = 198
2. Letter with invitation to make an appointment n = 206
3. Letter with fixed appointment n = 168
4. Control group (usual care) n = 185
Outcomes Pap smear uptake determined by administrative records
Notes Follow-up period was 1 year and recommended screening interval 2 years, so some
women may have been screened after study period but within recommended interval
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Pritchard 1995 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Eligible women were randomly allocated
to one of four groups using a table of ran-
dom numbers”
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk % analysed: 100% (757/757)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
Rimer 1999
Methods Design - RCT
Baseline comparability - not stated
Follow-up - 16 months
37/889 women died before the follow up interview, and a further 24% could not be
reached due to disconnected phones, 2% were not eligible for follow-up interview due
to health reasons and 2% refused to participate
Participants Country - USA
Setting - Community health centre
Initial screening status - unclear
Adult users (over the age of 18 years) of the Lincoln Community Health Centre (which
serves 30% of the Black population and is the most important provider of care for low-
income
Inclusion criteria - aged 18 years or over; client of medical center who had visited center
in previous 18 months
Exclusion criteria - not stated
Interventions Based on Transtheoretical Model
1. Provider prompting intervention only (202 analysed)
2. Provider prompting and tailored educational print communications (204 analysed)
3. Provider prompting, tailored educational print communications and tailored tele-
phone counselling (213 analysed)
1318 participants (men and women) of whom 889 eligible women were randomised,
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Rimer 1999 (Continued)
but study only gives breakdown of women analysed by treatment arm
Outcomes Pap smear uptake determined by self-report via questionnaire
Notes The information presented seem to be part of a larger study looking at the uptake
of cancer screening in general, although only data on female participants attending
mammography, Pap smear and CBE were presented. The use of a telephone to collect
information about participants, as well as part of the interventions may not have been
appropriate as the study looked at screening behaviour among low income participants,
many of whom had to be excluded because their telephone line had been disconnected.
Difficult to assess which part of the invention is effective
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
High risk % analysed: 70% (619/889)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
Risi 2004
Methods Design - RCT
Baseline comparability - not reported
Follow-up - 6 months
Participants Country - South Africa
Setting - Community. Peri-urban squatter community near Cape Town
658 women
Initial screening status - unclear
Inclusion criteria: Women aged 35 to 65 years resident in Khayelitsha who gave verbal
consent.
Exclusion criteria - not stated
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Risi 2004 (Continued)
Interventions 1. Photo-comic with a storyline including scenarios based on cervical screening and
common reasons for not participating in screening programme. n = 289
2. Photo-comic containing no health care messages. n = 389
Outcomes Self-reported Pap smear uptake
Notes After photo-comic intervention, a radio intervention involving similar storylines to the
intervention comic was broadcast. This part of the study was not randomised and is not
included in the analysis in this review
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk “Sealed envelope containing a randomly
allocated photo-comic was provided.” No
comment regarding opacity of envelope
made
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk > 99.8% analysed. One subject lost to fol-
low up
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
Rivers 2005
Methods Design - RCT
Baseline comparability - Baseline demographics of all women reported, but not broken
down into intervention arms
Follow-up - 12 months
Participants Country - USA
Setting - Urban community health clinic
441 women participated. Women were approached in the waiting room when attending
the clinic.Women attending for obstetric or gynaecological reasonswere not approached.
Initial screening status - unclear
Inclusion criteria: Women aged 18 to 65 years.
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Rivers 2005 (Continued)
Exclusion criteria - not stated
Interventions 1. 10 minute video focusing on prevention of cervical cancer. Message gain-framed
2. 10 minute video focusing on prevention of cervical cancer. Message loss-framed
3. 10 minute video focusing on detection of cervical cancer. Message gain-framed
4. 10 minute video focusing on detection of cervical cancer. Message loss-framed
Outcomes Self-reported uptake of Pap smear
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated table of randomly
sorted combinations of conditions
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
High risk % analysed: 78% (343/441)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias High risk Telephone call at 6 months may have acted
as a prompt to uptake and influence 12
month data
Number of recruits assigned to each inter-
vention is not stated. We have assumed a 1:
1:1:1 ratio with 110 in each intervention
Robson 1989
Methods Design - RCT
Baseline comparability - no significant differences were found between the study groups
in terms of the variables examined
Follow-up - 2 years
Women with hysterectomies were excluded from analyses. Trial discontinued after 2
years (versus 3 years), as GPs were no longer willing to exclude half the patients from
accessing the health promotion nurse
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Robson 1989 (Continued)
Participants Country - UK
Setting - General practice
Initial screening status - due
Men and women registered with a general practice in inner London (UK)
Inclusion criteria - aged 30 to 65 years; registered with practice and living in area
Exclusion criteria - hysterectomy
Interventions 1. Patients had open access to a health promotion nurse and had their risk factors assessed
and followed up by both their GP and the nurse n=799
2. Control, usual care (i.e. managed by GP alone) n=806
Outcomes Pap smear uptake determined by administrative records
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Patients ... were included and randomly
allocated
(with random number tables) to control or
intervention
groups”.
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk % analysed: 1605/1605 (100%)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias High risk “Although the trial had been designed to
last three
years, it was stopped after two years because
participating
doctors were not prepared to continue ex-
cluding half the practice from access to the
health promotion nurse”
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Segnan 1998
Methods Design - RCT
Baseline comparability - no significant differences were found between the study groups
in terms of the variables examined
Follow-up - 1 year
Participants Country - Italy
Setting - GP practice in national screening programme
Initial screening status - due
8385 women attending GPs in Turin who were part of the population based screening
programme (’Prevenzione Serena’)
Inclusion criteria - aged 25 to 64 years; resident of Turin
Exclusion criteria - previously diagnosed cervical cancer;suffering from terminal illness
or severe psychiatric symptoms
Interventions 1. Personal letter signed by GP with prefixed appointment (Control) n = 2100
2. Personal letter, signed by GP prompting appointment, n = 2093
3. Personal letter signed by program co-ordinator with prefixed appointment n = 2094
4. Personal letter with extended text signed by GP with prefixed appointment n = 2098
Outcomes Pap smear uptake determined by administrative records
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Assignment to the different groups was
performed automatically, following a ran-
domised block design (block=GP)”
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk % analysed: 100% (8385/8385)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
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Somkin 1997
Methods Design - RCT
Baseline comparability - no differences between study groups in terms of age
Follow-up - 6 months
Participants Country - USA
Setting - HMO
Initial screening status - due
7077 female HMO members
Inclusion criteria - aged 20 to 64 years; no prior Pap smear in the previous 36 months;
residents of study area; were continuously enrolled as a member of the HMO for the
previous 36 months
Exclusion criteria - not stated
Interventions 1. Letter inviting women to make an appointment n = 1188
2. Physician reminder and letter to patient inviting appointment n = 1188
3. Usual care (required a referral from physician) n = 1188
Outcomes Pap smear uptake determined by administrative records
Notes The authors list the following study limitations: smears obtained outside the HMOwere
not recorded; the chart reminder intervention required the health provider to review the
chart; the study had insufficient power to detect interactions effects between interventions
and covariates, and within strata
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk % analysed: 100% (3564/3564)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
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Stein 2005
Methods Design - RCT
Baseline comparability - no differences between study groups in terms of age
Follow-up - 3months
Participants Country - UK
Setting - Community. Devon, UK.
Initial screening status - overdue. 1140 women. No record of screening in past 15 years
Inclusion criteria - aged 39 to 64 years; no record of screening in past 15 years
Exclusion criteria - deceased, not resident in Devon, undergone hysterectomy, severe
learning disability
Interventions 1. Control. No Intervention. n = 285
2. Telephone call. Telephone call from experienced research nurse using a prepared script.
Maxiumum of three attempts were made on consecutive days. n = 285
3. Letter from Health Authority District Cervical Screening Commisioner on behalf of
National Cervical Screening Programme. n = 285
4. Letter from a well known journalist and broadcaster (Claire Rayner) who is also Chair
of the Patients Association. n = 285
Outcomes Pap smear uptake as recorded on the Devon Patient and Practitioners Services Agency
database
Notes Cost effectiveness analysis also performed. Average cost per attender was £145.12 for
telephone call, £14.29 for letter from commissioner and £37.14 for letter from celebrity
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “The sample was drawn randomly from the
sampling frame using Microsoft Excel.”
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
High risk % analysed: 73% (304/1140)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
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Sung 1997
Methods Design - RCT
Baseline comparability - no significant differences between study groups in terms of
those variables examined
Follow-up - 6 months
Participants Country - USA
Setting - Community
Initial screening status - due
321 low income African- American women from an inner-city community health centre
Inclusion criteria - African- American; aged 18 years or older
Exclusion criteria - hysterectomy; history of cervical cancer
Interventions 1. Lay health workers visited women three times to provide a culturally sensitive educa-
tional program emphasising need for screening through printed material and video n =
163
2. Control group received educational information on completion of follow-up n = 158
Outcomes Pap smear uptake determined by self-report via interview
Notes Loss to follow-up and Hawthorne effect may have biased the effects of the intervention,
however an intention to intervene analysis was also carried out with the aim of providing
a conservative estimate of the effect size
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
High risk % analysed: 61% (195/321)
Lay health workers: 93/163 (57%)
Control: 102/158 (65%)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
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Taylor 2002
Methods Design - RCT
Baseline comparability - no significant differences between study groups in terms of
those variables examined
Follow-up - 6months
Participants Country - USA
Setting - Chinese Community in Seattle and Washington
Initial screening status - Due
Inclusion criteria - 20 to 69 years, spoke Cantonese, Mandarin or English; no history
of cervical cancer; not had hysterectomy; not had smear in last 2 years and/or did not
intend to have Pap smear in the next 2 years
Interventions 1. Outreach worker intervention: Home visit including videos, motivational pamphlet,
tailored counselling, fact sheet and educational brochure. Follow up with telephone call
with tailored counselling. Assistance also provided to arrange and attend appointment
2. Direct mail intervention: Packet including video, motivational pamphlet, fact sheet
and educational brochure
3. Usual care
Outcomes Pap smear within previous 2 years. Self reported by questionnaire and cross-checked with
medical records where possible
Notes “Groups of women were randomly assigned every month over the 6-month period.”
Our understanding is that this refers to accrual date rather than referring the quasi-
randomisation
Intention to have smear in next 2 years also recorded.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk % analysed: 83% (402/482) for all out-
comes
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
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Vogt 2003
Methods Design - RCT
Baseline comparability - no significant differences between study groups in terms of
those variables examined
Follow-up - 12 weeks
Participants Country - USA
Setting - Managed care organisation (NWKP) in Portland, Oregon
Initial screening status - Due
Inclusion criteria - 18 to 70 years; 3 years continuous membership of NWKP; no history
of cervical cancer or cervical dysplasia; not had hysterectomy; not had Pap smear in past
3 years
Exclusion criteria - women who no longer had a valid local address or phone
Interventions 1. Usual care control
2. Letter/letter intervention: Subjects were sent a letter and relevant brochure. Women
who had not attended for screening within 6 weeks were sent a further letter emphasising
the importance of screening and providing a number to call
3. Letter/phone intervention: Letter and brochure as above. Women who had not at-
tended for screening within 6 weeks received a telephone call by study interventionist
who offered to schedule appointments, answer questions, address barriers and concerns
and discussing the importance of screening
4. Phone/phone intervention: Subjects in this group received two sequential telephone
calls, the second coming 6 weeks after the first if they had not been screened in the
interim.Contents of the initial letter and phone scripts were similar. Follow-up telephone
calls were by study interventionist, as above
Outcomes Pap smear uptake as recorded on care organisation pathology database
Notes Cost effectiveness analysis also performed. The letter/letter intervention produced one
additional Pap smear for $185. The phone/phone intervention cost $305 and the letter/
phone intervention cost $1117 for each additional Pap smear
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
High risk % analysed: 72% (866/1200)
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Vogt 2003 (Continued)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
Ward 1991
Methods Design - RCT
Baseline comparability - no significant differences between the study groups in terms of
factors studied
Follow-up - 1month
Participants Country - Australia
Setting - General practice
Initial screening status - due
204 female patients of 16 GPs in the inner metropolitan region of Sydney
Inclusion criteria - women: aged 20 to 65 years; provided consent
physicians: provided consent; complied with study procedures
Exclusion criteria - women: pregnant; had smear in past year; attending for smear that
day; hysterectomy; never sexually active with male partner; insufficient command of
English to complete questionnaire
physicians: worked < 20 hrs/week; were on leave/sick leave at time or recruitment; were
expected to take leave during the study period; did not have the equipment to take smears
Interventions 1. Minimal intervention: GP advised eligible women of need for smear and offered to
perform it immediately. Those not consenting advised to make appointment for smear
within a week n=99
2.Maximal intervention: GP advised woman of need for smear and offered to perform it
immediately; GP attempted to persuade those not consenting during that consultation
by exploring barriers and reasons for self-exclusions. If still did not consent, GP advised
making an appointment for smear within a week n=103
Outcomes Pap smear uptake determined by administrative records
Notes Fidelity of intervention implementation could not be checked; audiotapes were available
for only a few consultations. One of the audiotapes recorded a time of 6sec taken to give
the maximal intervention (shortest time in minimal intervention was 10sec)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
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Ward 1991 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk % analysed: 91% (184/202)
By treatment arm:
Minimal intervention: 95/99 (96%)
Maximal intervention: 89/103 (86%)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
Wilson 1987
Methods Design - RCT
Baseline comparability - no significant differences between the study groups in terms of
mean age
Follow-up - 3 weeks from final invitation letter
Participants Country - UK
Setting - National Screening Programme
Initial screening status - due, recorded as never having a smear
250 randomly selected women from five general practices (50 women per practice) in
the Nottingham Health Authority area
Inclusion criteria - aged 45 to 65 years; no record of having a previous smear
Exclusion criteria - hysterectomy or other medical condition
Interventions 1. Letter of invitation to make an appointment + two reminders, n = 125
2. Sent an appointment + two reminders, n = 125
Outcomes Pap smear uptake determined by administrative records
Notes Only published as a letter. Final numbers of study participants is small compared to the
initial study population (588 women who fulfilled the study criteria were not included)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Low risk Centralised allocation was used
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Wilson 1987 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk % analysed: 96% (240/250)
By treatment arm:
Letter invitation: 122/125 (98%)
Appointment: 118/125 (94%)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judge-
ment
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Al Saifafi 2009 Not RCT. Questionairre responses only.
Baele 1998 Quasi-RCT
Boissel 1995 Interventions targeted at General Practitioners rather than woman
Bonevski 1999 Interventions targeted at General Practitioners rather than woman
Brewster 2002 Comparisons of study recruitment strategies not of screening uptake
Campbell 1997 Intervention aimed at both the participants and the physician and data does not allow effects of the two
components to be examined independently. Interventions aimed at physicians are excluded from this
review
Cecchini 1989 Interventions targeted at “promoting general practitioners’ cooperation” and not at women
Chumworathayi 2007 Quasi-RCT
Corkrey 2005 Number of uptake cases in each group is not reported. Increase uptake of 0.43% reported in intervention
group but no P-value or 95%CI reported
Del Mar 1995 Intervention more concerned with obtaining more up to date addresses for participants rather than strictly
increasing the uptake of screening
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(Continued)
Dignan 1996 Attendance for screening over the previous year was measured, but data were gathered only 6months post
intervention. Therefore, it is unclear how the intervention affected uptake as participants may have been
screened prior to receiving the intervention
Dignan 1998 Attendance for screening over the previous year was measured, but data were gathered only 6months post
intervention. Therefore, it is unclear how the intervention affected uptake as participants may have been
screened prior to receiving the intervention
Engelstad 2005 Intervention aimed at improving follow-up following abnormal results rather than initial screening uptake
German 1995 The study examines the effect of the intervention on the uptake of overall preventive visits and the data is
not specifically broken down into individual screening tests and procedures
Gotay 2000 Outcome reported as “Ever had Pap test”. This only captures new uptake rather than total uptake at follow
up
Hancock 2001 Not possible to extract relevant data for purposes of this review
Hicks 1997 Quasi-RCT
Hillman 1998 Interventions targeted at GP practices and not at women.
Holloway 2003 Outcomes reported at timing interval of smear uptake rather than number of women reporting uptake
Hou 2002 Quasi-RCT
Hou 2005 Quasi-RCT
Jenkins 1999 Not an RCT
Karwalajtys 2007 Not RCT
Katz 2007 Intervention was aimed at increasing mammography uptake
Lam 2003 Initial data only. Full data included in Mock 2007.
Lantz 1995 Quasi-RCT
Lantz 1996 Quasi-RCT
Lauver 1990 Intervention aimed at improving follow-up following abnormal results rather than initial screening uptake
Levine 2003 Quasi-RCT
Litzelman 1993 Interventions targeted at physicians to improve uptake and not at women
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(Continued)
Lynch 2004 Cost effectiveness study. Data reported as uptake of both cervical screening and mammography and not
reported separately
Manfredi 1998 Interventions targeted at physicians to improve uptake and not at women
Marcus 1992 Cluster quasi-RCT
Marcus 1998 Intervention aimed at improving follow-up following abnormal results rather than initial screening uptake
Margolis 1998 Quasi-RCT
Maxwell 2003 Quasi-RCT. “....[women] wanted to attend the same group session, 5-10 women were randomised to one
study condition and the next group of 5-10 women to the other.”
Mayer 1992 Age range is 65years and older and therefore does not represent the generally accepted age group for cervical
screening programmes
Miller 1999 Intervention aimed at improving follow-up following abnormal results rather than initial screening uptake
Miller 2007 Not RCT. Qualitative study
Mitchell 1991 Not an RCT: The educational campaign was not randomly assigned and 2000 women were only randomly
selected within each of the campaign study groups to receive the personal invitation letter
Mitchell 1997 Not RCT
Newell 2002 RCT. However data is not presented in a way that is interpretable for purposes of the review
Nguyen 2000 Interventions targeted at physicians to improve uptake and not at women
Park 2005 LIkely Quasi-RCT. “...randomly assigned to the experimental or control group in order of contact...”
Paskett 1990 Quasi-RCT
Paskett 1995 Intervention aimed at improving follow-up following abnormal results rather than initial screening uptake
Paskett 1999 Not RCT. “..mixed cohort/cross-sectional design.”
Paul 2003 Outcome was enrolment to Pap smear reminder service
Perkins 2007 Not RCT. Cross-sectional study.
Peters 1999 Cluster RCT examining anxiety among women with mild dyskaryosis and the aim of the educational
intervention was to reduce anxiety so scope differs to that of this review
Philips 2006 Outcome is “willingness to pay” rather than screening uptake
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(Continued)
Powers 1992 Study examined attendance for a number of screening tests and did not separate data according to the type
of test
Roetzheim 2004 Interventions targeted at clinic staff and not at women.
Roetzheim 2005 Interventions targeted at attempting “to change systematically the behaviours of all office staff ”
Ruffin 2004 Age range is 50 years and older and therefore does not represent a majority of the generally accepted age
group for cervical screening programmes
Loss to follow up was reported by practice, but not in terms of numbers of recruits or treatments arms
Percentage uptake rates of 2 and 3 year follow up does not use baseline as a reference point
Sankaranarayanan 2003 Outcome is “effectiveness of VIA screening” not uptake of screening
Shelley 1991 Not RCT
Stewart 1994 Intervention aimed at improving follow-up following abnormal results rather than initial screening uptake
Takacs 2004 Intervention aimed at improving follow-up following abnormal results rather than initial screening uptake
Tomlinson 2004 Intervention aimed at improving follow-up following abnormal results rather than initial screening uptake
Torres-Mejia 2000 Recruits were “systematically assigned.” Not RCT
Valanis 2003 Age range is 50-69 years and therefore does not represent a majority of the generally accepted age group
for cervical screening programmes
Ward 1999 Quasi-RCT
Yancey 1995 Quasi-RCT
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D A T A A N D A N A L Y S E S
Comparison 1. Invitation vs control
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Uptake of screening 15 105881 Risk Ratio (IV, Random, 95% CI) 1.65 [1.44, 1.90]
1.1 Invitation letter vs control 12 99651 Risk Ratio (IV, Random, 95% CI) 1.44 [1.24, 1.67]
1.2 Telephone invitation vs
control
4 2342 Risk Ratio (IV, Random, 95% CI) 2.16 [1.70, 2.74]
1.3 Face to face invitation vs
control
1 121 Risk Ratio (IV, Random, 95% CI) 9.15 [0.50, 166.30]
1.4 Letter with open invitation
to make appointment vs
control
4 2998 Risk Ratio (IV, Random, 95% CI) 1.61 [1.15, 2.26]
1.5 Letter with fixed
appointment vs control
1 177 Risk Ratio (IV, Random, 95% CI) 1.80 [1.04, 3.11]
1.6 Letter invitation with
telephone follow up vs control
1 276 Risk Ratio (IV, Random, 95% CI) 3.14 [1.97, 5.01]
1.7 Celebrity letter invitation
vs control
1 316 Risk Ratio (IV, Random, 95% CI) 2.15 [0.25, 18.15]
Comparison 2. GP invitation letter vs invitation letter from other authority sources
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Uptake of screening 2 Risk Ratio (IV, Random, 95% CI) Totals not selected
1.1 GP invitation letter vs
health clinic invitation letter
1 Risk Ratio (IV, Random, 95% CI) 0.0 [0.0, 0.0]
1.2 GP invitation letter
vs invitation letter from
programme coordinator
1 Risk Ratio (IV, Random, 95% CI) 0.0 [0.0, 0.0]
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Comparison 3. Personal invitation vs invitation letter
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Uptake of screening 3 Risk Ratio (IV, Random, 95% CI) Subtotals only
1.1 Telephone invitation vs
invitation letter
2 1899 Risk Ratio (IV, Random, 95% CI) 1.32 [1.15, 1.53]
1.2 Face-to-face invitation vs
invitation letter
1 123 Risk Ratio (IV, Random, 95% CI) 2.1 [0.40, 11.05]
Comparison 4. Letter with fixed appointment vs letter with open invitation to make an appointment
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Uptake of screening 4 4706 Risk Ratio (IV, Random, 95% CI) 1.57 [1.43, 1.72]
Comparison 5. Education vs control
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Uptake of screening 6 Risk Ratio (IV, Random, 95% CI) Subtotals only
1.1 Education (printed
material) vs control
3 502 Risk Ratio (IV, Random, 95% CI) 1.11 [0.88, 1.41]
1.2 Education (miscellaneous)
vs control
2 295 Risk Ratio (IV, Random, 95% CI) 1.92 [1.24, 2.97]
1.3 Education (face-to-face
home visits) vs control
3 1318 Risk Ratio (IV, Random, 95% CI) 2.33 [1.04, 5.23]
Comparison 6. Education vs other
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Uptake of screening 4 Risk Ratio (IV, Random, 95% CI) Totals not selected
1.1 Education (printed
material) vs health clinic
invitation letter
1 Risk Ratio (IV, Random, 95% CI) 0.0 [0.0, 0.0]
1.2 Education (printed
material) vs GP invitation letter
1 Risk Ratio (IV, Random, 95% CI) 0.0 [0.0, 0.0]
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1.3 Education (format
unknown) vs enhanced risk
assessment
1 Risk Ratio (IV, Random, 95% CI) 0.0 [0.0, 0.0]
1.4 Education (printed
material) vs education
(video/slide)
1 Risk Ratio (IV, Random, 95% CI) 0.0 [0.0, 0.0]
1.5 Intensive peer health
advice vs other
1 Risk Ratio (IV, Random, 95% CI) 0.0 [0.0, 0.0]
2 Lay health outreach worker and
media education vs media
education
1 Risk Ratio (IV, Random, 95% CI) Subtotals only
3 Standard invitation and
printed education vs standard
invitation
1 Risk Ratio (IV, Random, 95% CI) Subtotals only
Comparison 7. Counselling vs control
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Uptake of screening 2 393 Risk Ratio (IV, Random, 95% CI) 1.23 [1.04, 1.45]
1.1 Face-to-face counselling vs
control
1 184 Risk Ratio (IV, Random, 95% CI) 1.23 [0.98, 1.55]
1.2 Telephone counselling vs
control
1 209 Risk Ratio (IV, Random, 95% CI) 1.22 [0.97, 1.55]
Comparison 8. Counselling vs other
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Uptake of screening 1 Risk Ratio (IV, Random, 95% CI) Totals not selected
1.1 Telephone counselling vs
provider prompts
1 Risk Ratio (IV, Random, 95% CI) 0.0 [0.0, 0.0]
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Comparison 9. Enhanced risk assessment vs control
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Uptake of screening 2 145 Risk Ratio (IV, Random, 95% CI) 1.52 [0.58, 3.95]
Comparison 10. Enhanced risk assessment vs other
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Uptake of screening 1 Risk Ratio (IV, Random, 95% CI) Totals not selected
Comparison 11. Access to health promotion nurse vs control
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Uptake of screening 1 Risk Ratio (IV, Random, 95% CI) Subtotals only
Comparison 12. Photocomic vs placebo comic
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Uptake of screening 1 Risk Ratio (IV, Random, 95% CI) Subtotals only
Comparison 13. Intensive recruitment attempts vs control
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Uptake of screening 1 Risk Ratio (IV, Random, 95% CI) Subtotals only
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Comparison 14. Message framing
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Gain versus loss message framing
(Detection)
1 Risk Ratio (IV, Random, 95% CI) Subtotals only
2 Gain versus loss message framing
(Prevention)
1 Risk Ratio (IV, Random, 95% CI) Subtotals only
3 Gain Message Framing:
Prevention vs Detection
1 Risk Ratio (IV, Random, 95% CI) Subtotals only
4 Loss Message Framing:
Prevention vs Detection
1 Risk Ratio (IV, Random, 95% CI) Subtotals only
Analysis 1.1. Comparison 1 Invitation vs control, Outcome 1 Uptake of screening.
Review: Interventions targeted at women to encourage the uptake of cervical screening
Comparison: 1 Invitation vs control
Outcome: 1 Uptake of screening
Study or subgroup Invitation Control Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Invitation letter vs control
Binstock 1997 202/763 125/763 7.5 % 1.62 [ 1.32, 1.97 ]
Bowman 1995 13/45 9/52 2.4 % 1.67 [ 0.79, 3.53 ]
Buehler 1997 19/178 13/208 2.8 % 1.71 [ 0.87, 3.36 ]
Burack 1998 280/964 270/964 8.2 % 1.04 [ 0.90, 1.19 ]
Burack 2003 371/1243 284/1228 8.3 % 1.29 [ 1.13, 1.47 ]
Del Mar 1998 36/359 39/330 4.8 % 0.85 [ 0.55, 1.30 ]
Hunt 1998 2/63 0/61 0.2 % 4.84 [ 0.24, 98.88 ]
Lancaster 1992 151/908 89/886 7.0 % 1.66 [ 1.30, 2.12 ]
McDowell 1989 38/184 18/165 3.9 % 1.89 [ 1.13, 3.18 ]
Morrell 2005 2630/59780 868/29919 8.7 % 1.52 [ 1.41, 1.64 ]
Pierce 1989 45/140 20/134 4.3 % 2.15 [ 1.35, 3.45 ]
Stein 2005 13/219 1/95 0.4 % 5.64 [ 0.75, 42.50 ]
Subtotal (95% CI) 64846 34805 58.5 % 1.44 [ 1.24, 1.67 ]
0.01 0.1 1 10 100
Favours Control Favours Invitation
(Continued . . . )
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(. . . Continued)
Study or subgroup Invitation Control Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Total events: 3800 (Invitation), 1736 (Control)
Heterogeneity: Tau2 = 0.03; Chi2 = 39.60, df = 11 (P = 0.00004); I2 =72%
Test for overall effect: Z = 4.80 (P < 0.00001)
2 Telephone invitation vs control
Binstock 1997 268/763 125/763 7.7 % 2.14 [ 1.78, 2.59 ]
McDowell 1989 30/189 18/165 3.7 % 1.46 [ 0.84, 2.51 ]
Stein 2005 4/111 1/95 0.4 % 3.42 [ 0.39, 30.11 ]
Vogt 2003 82/163 16/93 4.3 % 2.92 [ 1.83, 4.68 ]
Subtotal (95% CI) 1226 1116 16.1 % 2.16 [ 1.70, 2.74 ]
Total events: 384 (Invitation), 160 (Control)
Heterogeneity: Tau2 = 0.01; Chi2 = 3.78, df = 3 (P = 0.29); I2 =21%
Test for overall effect: Z = 6.29 (P < 0.00001)
3 Face to face invitation vs control
Hunt 1998 4/60 0/61 0.2 % 9.15 [ 0.50, 166.30 ]
Subtotal (95% CI) 60 61 0.2 % 9.15 [ 0.50, 166.30 ]
Total events: 4 (Invitation), 0 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.50 (P = 0.13)
4 Letter with open invitation to make appointment vs control
Bowman 1995 7/41 9/52 1.8 % 0.99 [ 0.40, 2.42 ]
Pritchard 1995 27/103 16/93 3.6 % 1.52 [ 0.88, 2.64 ]
Somkin 1997 230/1188 108/1188 7.3 % 2.13 [ 1.72, 2.64 ]
Vogt 2003 53/240 16/93 4.0 % 1.28 [ 0.77, 2.13 ]
Subtotal (95% CI) 1572 1426 16.8 % 1.61 [ 1.15, 2.26 ]
Total events: 317 (Invitation), 149 (Control)
Heterogeneity: Tau2 = 0.06; Chi2 = 6.02, df = 3 (P = 0.11); I2 =50%
Test for overall effect: Z = 2.75 (P = 0.0060)
5 Letter with fixed appointment vs control
Pritchard 1995 26/84 16/93 3.7 % 1.80 [ 1.04, 3.11 ]
Subtotal (95% CI) 84 93 3.7 % 1.80 [ 1.04, 3.11 ]
Total events: 26 (Invitation), 16 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 2.10 (P = 0.036)
6 Letter invitation with telephone follow up vs control
Vogt 2003 99/183 16/93 4.4 % 3.14 [ 1.97, 5.01 ]
Subtotal (95% CI) 183 93 4.4 % 3.14 [ 1.97, 5.01 ]
Total events: 99 (Invitation), 16 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 4.82 (P < 0.00001)
7 Celebrity letter invitation vs control
0.01 0.1 1 10 100
Favours Control Favours Invitation
(Continued . . . )
78Interventions targeted at women to encourage the uptake of cervical screening (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(. . . Continued)
Study or subgroup Invitation Control Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Stein 2005 5/221 1/95 0.4 % 2.15 [ 0.25, 18.15 ]
Subtotal (95% CI) 221 95 0.4 % 2.15 [ 0.25, 18.15 ]
Total events: 5 (Invitation), 1 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.70 (P = 0.48)
Total (95% CI) 68192 37689 100.0 % 1.65 [ 1.44, 1.90 ]
Total events: 4635 (Invitation), 2078 (Control)
Heterogeneity: Tau2 = 0.05; Chi2 = 90.11, df = 23 (P<0.00001); I2 =74%
Test for overall effect: Z = 7.24 (P < 0.00001)
Test for subgroup differences: Chi2 = 16.95, df = 6 (P = 0.01), I2 =65%
0.01 0.1 1 10 100
Favours Control Favours Invitation
Analysis 2.1. Comparison 2 GP invitation letter vs invitation letter from other authority sources, Outcome
1 Uptake of screening.
Review: Interventions targeted at women to encourage the uptake of cervical screening
Comparison: 2 GP invitation letter vs invitation letter from other authority sources
Outcome: 1 Uptake of screening
Study or subgroup GP invitation letter
Other
invitation
letter Risk Ratio Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 GP invitation letter vs health clinic invitation letter
Bowman 1995 13/45 7/41 1.69 [ 0.75, 3.82 ]
2 GP invitation letter vs invitation letter from programme coordinator
Segnan 1998 945/2013 837/2015 1.13 [ 1.05, 1.21 ]
0.2 0.5 1 2 5
Favours other letter Favours GP letter
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Analysis 3.1. Comparison 3 Personal invitation vs invitation letter, Outcome 1 Uptake of screening.
Review: Interventions targeted at women to encourage the uptake of cervical screening
Comparison: 3 Personal invitation vs invitation letter
Outcome: 1 Uptake of screening
Study or subgroup Personal invitation Invitation letter Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Telephone invitation vs invitation letter
Binstock 1997 268/763 202/763 89.0 % 1.33 [ 1.14, 1.55 ]
McDowell 1989 38/184 30/189 11.0 % 1.30 [ 0.84, 2.01 ]
Subtotal (95% CI) 947 952 100.0 % 1.32 [ 1.15, 1.53 ]
Total events: 306 (Personal invitation), 232 (Invitation letter)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.01, df = 1 (P = 0.93); I2 =0.0%
Test for overall effect: Z = 3.82 (P = 0.00013)
2 Face-to-face invitation vs invitation letter
Hunt 1998 4/60 2/63 100.0 % 2.10 [ 0.40, 11.05 ]
Subtotal (95% CI) 60 63 100.0 % 2.10 [ 0.40, 11.05 ]
Total events: 4 (Personal invitation), 2 (Invitation letter)
Heterogeneity: not applicable
Test for overall effect: Z = 0.88 (P = 0.38)
0.05 0.2 1 5 20
Favours letter Favours personal
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Analysis 4.1. Comparison 4 Letter with fixed appointment vs letter with open invitation to make an
appointment, Outcome 1 Uptake of screening.
Review: Interventions targeted at women to encourage the uptake of cervical screening
Comparison: 4 Letter with fixed appointment vs letter with open invitation to make an appointment
Outcome: 1 Uptake of screening
Study or subgroup
Letter -fixed
appointment Letter -invitation Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Bowman 1995 13/45 7/41 1.2 % 1.69 [ 0.75, 3.82 ]
Pritchard 1995 26/84 27/103 4.0 % 1.18 [ 0.75, 1.86 ]
Segnan 1998 759/2100 474/2093 86.8 % 1.60 [ 1.45, 1.76 ]
Wilson 1987 56/118 39/122 8.0 % 1.48 [ 1.08, 2.05 ]
Total (95% CI) 2347 2359 100.0 % 1.57 [ 1.43, 1.72 ]
Total events: 854 (Letter -fixed appointment), 547 (Letter -invitation)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.76, df = 3 (P = 0.62); I2 =0.0%
Test for overall effect: Z = 9.72 (P < 0.00001)
Test for subgroup differences: Not applicable
0.2 0.5 1 2 5
Favours invitation Favours fixed
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Analysis 5.1. Comparison 5 Education vs control, Outcome 1 Uptake of screening.
Review: Interventions targeted at women to encourage the uptake of cervical screening
Comparison: 5 Education vs control
Outcome: 1 Uptake of screening
Study or subgroup Education Control Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Education (printed material) vs control
Bowman 1995 10/54 9/52 8.5 % 1.07 [ 0.47, 2.42 ]
McAvoy 1991 14/131 3/62 3.8 % 2.21 [ 0.66, 7.41 ]
Rimer 1999 57/101 53/102 87.7 % 1.09 [ 0.84, 1.40 ]
Subtotal (95% CI) 286 216 100.0 % 1.11 [ 0.88, 1.41 ]
Total events: 81 (Education), 65 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.28, df = 2 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 0.90 (P = 0.37)
2 Education (miscellaneous) vs control
Greene 1999 27/49 10/40 53.9 % 2.20 [ 1.22, 3.99 ]
Taylor 2002 34/139 10/67 46.1 % 1.64 [ 0.86, 3.11 ]
Subtotal (95% CI) 188 107 100.0 % 1.92 [ 1.24, 2.97 ]
Total events: 61 (Education), 20 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.44, df = 1 (P = 0.51); I2 =0.0%
Test for overall effect: Z = 2.94 (P = 0.0033)
3 Education (face-to-face home visits) vs control
McAvoy 1991 272/964 3/62 24.1 % 5.83 [ 1.92, 17.67 ]
Sung 1997 27/44 26/52 40.6 % 1.23 [ 0.86, 1.76 ]
Taylor 2002 50/129 10/67 35.3 % 2.60 [ 1.41, 4.79 ]
Subtotal (95% CI) 1137 181 100.0 % 2.33 [ 1.04, 5.23 ]
Total events: 349 (Education), 39 (Control)
Heterogeneity: Tau2 = 0.39; Chi2 = 9.71, df = 2 (P = 0.01); I2 =79%
Test for overall effect: Z = 2.05 (P = 0.041)
0.05 0.2 1 5 20
Favours control Favours education
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Analysis 6.1. Comparison 6 Education vs other, Outcome 1 Uptake of screening.
Review: Interventions targeted at women to encourage the uptake of cervical screening
Comparison: 6 Education vs other
Outcome: 1 Uptake of screening
Study or subgroup Education material Other Risk Ratio Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Education (printed material) vs health clinic invitation letter
Bowman 1995 10/54 7/41 1.08 [ 0.45, 2.61 ]
2 Education (printed material) vs GP invitation letter
Bowman 1995 10/54 13/45 0.64 [ 0.31, 1.32 ]
3 Education (format unknown) vs enhanced risk assessment
Greene 1999 27/49 31/49 0.87 [ 0.63, 1.21 ]
4 Education (printed material) vs education (video/slide)
McAvoy 1991 57/219 80/263 0.86 [ 0.64, 1.14 ]
5 Intensive peer health advice vs other
Allen 2001 1230/1376 1129/1287 1.02 [ 0.99, 1.05 ]
0.2 0.5 1 2 5
Favours other Favours education
Analysis 6.2. Comparison 6 Education vs other, Outcome 2 Lay health outreach worker and media
education vs media education.
Review: Interventions targeted at women to encourage the uptake of cervical screening
Comparison: 6 Education vs other
Outcome: 2 Lay health outreach worker and media education vs media education
Study or subgroup Media education only
Lay health outreach
worker and media
education Risk Ratio Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Mock 2007 74/161 39/144 1.70 [ 1.24, 2.33 ]
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Total events: 74 (Media education only), 39 (Lay health outreach worker and media education)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
0.2 0.5 1 2 5
Favours Media only Favours LHWO and Media
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Analysis 6.3. Comparison 6 Education vs other, Outcome 3 Standard invitation and printed education vs
standard invitation.
Review: Interventions targeted at women to encourage the uptake of cervical screening
Comparison: 6 Education vs other
Outcome: 3 Standard invitation and printed education vs standard invitation
Study or subgroup Modified Standard Risk Ratio Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Eaker 2004 1638/6065 1566/6092 1.05 [ 0.99, 1.11 ]
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Total events: 1638 (Modified), 1566 (Standard)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
0.5 0.7 1 1.5 2
Favours standard Favours modified
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Analysis 7.1. Comparison 7 Counselling vs control, Outcome 1 Uptake of screening.
Review: Interventions targeted at women to encourage the uptake of cervical screening
Comparison: 7 Counselling vs control
Outcome: 1 Uptake of screening
Study or subgroup Counselling Control Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Face-to-face counselling vs control
Ward 1991 60/89 52/95 50.5 % 1.23 [ 0.98, 1.55 ]
Subtotal (95% CI) 89 95 50.5 % 1.23 [ 0.98, 1.55 ]
Total events: 60 (Counselling), 52 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.75 (P = 0.080)
2 Telephone counselling vs control
Rimer 1999 68/107 53/102 49.5 % 1.22 [ 0.97, 1.55 ]
Subtotal (95% CI) 107 102 49.5 % 1.22 [ 0.97, 1.55 ]
Total events: 68 (Counselling), 53 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.68 (P = 0.094)
Total (95% CI) 196 197 100.0 % 1.23 [ 1.04, 1.45 ]
Total events: 128 (Counselling), 105 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.00, df = 1 (P = 0.97); I2 =0.0%
Test for overall effect: Z = 2.42 (P = 0.015)
Test for subgroup differences: Chi2 = 0.00, df = 1 (P = 0.97), I2 =0.0%
0.5 0.7 1 1.5 2
Favours control Favours counselling
Analysis 8.1. Comparison 8 Counselling vs other, Outcome 1 Uptake of screening.
Review: Interventions targeted at women to encourage the uptake of cervical screening
Comparison: 8 Counselling vs other
Outcome: 1 Uptake of screening
Study or subgroup Counselling Other Risk Ratio Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Telephone counselling vs provider prompts
Rimer 1999 68/107 57/101 1.13 [ 0.90, 1.41 ]
0.5 0.7 1 1.5 2
Favours other Favours counselling
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Analysis 9.1. Comparison 9 Enhanced risk assessment vs control, Outcome 1 Uptake of screening.
Review: Interventions targeted at women to encourage the uptake of cervical screening
Comparison: 9 Enhanced risk assessment vs control
Outcome: 1 Uptake of screening
Study or subgroup
Enhanced
risk
assessment Control Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Greene 1999 31/49 10/40 47.6 % 2.53 [ 1.42, 4.51 ]
Kreuter 1996 15/24 21/32 52.4 % 0.95 [ 0.64, 1.42 ]
Total (95% CI) 73 72 100.0 % 1.52 [ 0.58, 3.95 ]
Total events: 46 (Enhanced risk assessment), 31 (Control)
Heterogeneity: Tau2 = 0.41; Chi2 = 7.45, df = 1 (P = 0.01); I2 =87%
Test for overall effect: Z = 0.85 (P = 0.39)
Test for subgroup differences: Not applicable
0.2 0.5 1 2 5
Favours control Favours assessment
Analysis 10.1. Comparison 10 Enhanced risk assessment vs other, Outcome 1 Uptake of screening.
Review: Interventions targeted at women to encourage the uptake of cervical screening
Comparison: 10 Enhanced risk assessment vs other
Outcome: 1 Uptake of screening
Study or subgroup
Enhanced
risk
assessment Other Risk Ratio Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Kreuter 1996 15/24 24/46 1.20 [ 0.79, 1.81 ]
0.5 0.7 1 1.5 2
Favours other Favours assessment
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Analysis 11.1. Comparison 11 Access to health promotion nurse vs control, Outcome 1 Uptake of screening.
Review: Interventions targeted at women to encourage the uptake of cervical screening
Comparison: 11 Access to health promotion nurse vs control
Outcome: 1 Uptake of screening
Study or subgroup Nurse access Control Risk Ratio Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Robson 1989 606/799 392/608 1.18 [ 1.10, 1.26 ]
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Total events: 606 (Nurse access), 392 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
0.5 0.7 1 1.5 2
Favours control Favours nurse
Analysis 12.1. Comparison 12 Photocomic vs placebo comic, Outcome 1 Uptake of screening.
Review: Interventions targeted at women to encourage the uptake of cervical screening
Comparison: 12 Photocomic vs placebo comic
Outcome: 1 Uptake of screening
Study or subgroup Photo-comic Control comic Risk Ratio Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Risi 2004 25/389 18/269 0.96 [ 0.53, 1.73 ]
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Total events: 25 (Photo-comic), 18 (Control comic)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
0.5 0.7 1 1.5 2
Favours control-comic Favours photo-comic
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Analysis 13.1. Comparison 13 Intensive recruitment attempts vs control, Outcome 1 Uptake of screening.
Review: Interventions targeted at women to encourage the uptake of cervical screening
Comparison: 13 Intensive recruitment attempts vs control
Outcome: 1 Uptake of screening
Study or subgroup Experimental Control Risk Ratio Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Oscarsson 2007 118/400 74/400 1.59 [ 1.24, 2.06 ]
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Total events: 118 (Experimental), 74 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
0.5 0.7 1 1.5 2
Favours control Favours intensive
Analysis 14.1. Comparison 14 Message framing, Outcome 1 Gain versus loss message framing (Detection).
Review: Interventions targeted at women to encourage the uptake of cervical screening
Comparison: 14 Message framing
Outcome: 1 Gain versus loss message framing (Detection)
Study or subgroup
Detection,
Gain
Framed
Detection,
Loss
Framed Risk Ratio Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Rivers 2005 15/37 19/37 0.79 [ 0.48, 1.30 ]
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Total events: 15 (Detection, Gain Framed), 19 (Detection, Loss Framed)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
0.2 0.5 1 2 5
Favours Loss Favours Gain
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Analysis 14.2. Comparison 14 Message framing, Outcome 2 Gain versus loss message framing (Prevention).
Review: Interventions targeted at women to encourage the uptake of cervical screening
Comparison: 14 Message framing
Outcome: 2 Gain versus loss message framing (Prevention)
Study or subgroup
Prevention,
Gain
Framed
Prevention,
Loss Framed Risk Ratio Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Rivers 2005 16/37 15/37 1.07 [ 0.62, 1.83 ]
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Total events: 16 (Prevention, Gain Framed), 15 (Prevention, Loss Framed)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
0.5 0.7 1 1.5 2
Favours Loss Favours Gain
Analysis 14.3. Comparison 14 Message framing, Outcome 3 Gain Message Framing: Prevention vs
Detection.
Review: Interventions targeted at women to encourage the uptake of cervical screening
Comparison: 14 Message framing
Outcome: 3 Gain Message Framing: Prevention vs Detection
Study or subgroup
Prevention,
Gain
Framed
Detection,
Gain
Framed Risk Ratio Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Rivers 2005 16/37 15/37 1.07 [ 0.62, 1.83 ]
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Total events: 16 (Prevention, Gain Framed), 15 (Detection, Gain Framed)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
0.5 0.7 1 1.5 2
Favours Detection Favours Prevention
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Analysis 14.4. Comparison 14 Message framing, Outcome 4 Loss Message Framing: Prevention vs
Detection.
Review: Interventions targeted at women to encourage the uptake of cervical screening
Comparison: 14 Message framing
Outcome: 4 Loss Message Framing: Prevention vs Detection
Study or subgroup
Prevention,
Loss
Framed
Detection,
Loss
Framed Risk Ratio Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Rivers 2005 15/37 19/37 0.79 [ 0.48, 1.30 ]
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Total events: 15 (Prevention, Loss Framed), 19 (Detection, Loss Framed)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
0.5 0.7 1 1.5 2
Favours Detection Favours Prevention
A D D I T I O N A L T A B L E S
Table 1. Details of secondary outcomes
Study details Interventions Secondary outcome(s) Results
Binstock 1997 1. Telephone call n = 1526 (1526
analysed) 2. Letter n = 1526 (1526
analysed) 3. Memo to woman’s pri-
mary provider n = 1526 (1,526 anal-
ysed) 4. Chart reminder affixed to
outside of woman’s medical record
n =1526 (1526 analysed) 5. Control
group n = 1526 (1526)
Costs Total estimated costs ($US) per inter-
vention: 1.$4,282; 2. $1,918; 3. $8,
933; 4. $1,0.90; 5. Not stated. Esti-
mated cost ($US) per additional Pap
smear performed: 1. $7.99; 2. $4.76; 3.
$22.96; 4. $2.99; 5. Not applicable
Byles 1995 1.
Personally addressed letter with sim-
ple information about Pap smears n=
? (1128 analysed) 2. Personally ad-
dressed letter combined with a series
of targeted behavioural prompts (e.
g. prompt cards) designed to address
aspects believed to be associatedwith
poor screening rates n=?(1098 anal-
ysed) 3. Control n=? (1414 analysed)
Acceptability of the intervention Number (%) of responding women re-
ceiving the intervention: 1. 154 (72%)
; 2. 134 (78%) letter, 100 (58%) card,
109 (64%) pamphlet; 3. Not applica-
ble. Number (%) of women responders
who said they had read the material
sent: 1. 147 (69%); 2. 128 (75%) let-
ter, 7 (4%) card, 101 (59%) pamphlet;
3. Not applicable. For intervention 1.
118/151 (78%) of the women said that
they were pleased to have the inter-
vention personally addressed to them,
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Table 1. Details of secondary outcomes (Continued)
only 1/151 (1%) said they were dis-
pleased and the remainder were not
sure. In intervention 2. 89/132 (68%)
were pleased, 3/132 (2%) were dis-
pleased and the remainder were unsure.
In intervention 1. 152/155 (98%) of
the women thought that the interven-
tion should be sent to all women, 2/
155 (1.3%) did not and the remainder
were unsure. In intervention 2. 124/
130 (95%) of women thought the in-
tervention should be sent to all women,
1/130 (1%) did not and the remainder
were unsure
McDowell 1989 1. GP letter and reminder letter after
21 days n = 367 (367 analysed)
2. Physician reminder n = 332 (332
analysed)
3. Telephone call n = 377 (377 anal-
ysed)
4. Control group n = 330 (330 anal-
ysed)
Costs The costs for the GP letter were $14.23
per screening gained, compared with
$11.75 assuming a salary of $60 per
hour (or $5.88 at $30 per hour ) per
screening gained
Greene 1999 1. Usual care n = 79 (? analysed) re-
ceived general dietary and health in-
formation
2. Cancer education n = 97 (? anal-
ysed) received general information
about cervical cancer risk factors and
screening recommendations
3. Cognitive behavioral intervention
n = 97 (? analysed) received feed-
back about personal risk for cancer
and engaged in a clinical interview
to enhance self-efficacy for preventa-
tive behaviour
Booking of appointments Women in group 1. were more likely
to schedule an appointment for a Pap
smear than those in group 3. (group
1.=79.4% versus group 3.= 36.7%,
P </= 0.0001). Women in group 1.
were also more likely to attend without
rescheduling the appointment (group
1.=63.9%versus group 3.= 35.4%, P </
= 0.001). Group 2. did not differ from
group 3. on these measures
Vogt 2003 1. Usual care control
2. Letter/letter intervention: Sub-
jects were sent a letter and relevant
brochure. Women who had not at-
tended for screening within 6 weeks
were sent a further letter emphasis-
ing the importance of screening and
providing a number to call
3. Letter/phone intervention: Let-
ter and brochure as above. Women
who had not attended for screening
Costs The letter/letter intervention produced
one additional Pap smear for $185. The
phone/phone intervention cost $305
and the letter/phone intervention cost
$1117 for each additional Pap smear
91Interventions targeted at women to encourage the uptake of cervical screening (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 1. Details of secondary outcomes (Continued)
within 6 weeks received a telephone
call by study interventionist who of-
fered to schedule appointments, an-
swer questions, address barriers and
concerns and discussing the impor-
tance of screening
4. Phone/phone intervention: Sub-
jects in this group received two se-
quential telephone calls, the second
coming 6 weeks after the first if they
had not been screened in the in-
terim. Contents of the initial letter
and phone scripts were similar. Fol-
low-up telephone calls were by study
interventionist, as above
Stein 2005 1.Control.No Intervention. n =285
2. Telephone call. Telephone call
from experienced research nurse us-
ing a prepared script. Maxiumum of
three attempts weremade on consec-
utive days. n = 285
3. Letter from Health Authority
District Cervical Screening Commi-
sioner on behalf of National Cervi-
cal Screening Programme. n = 285
4. Letter from a well known journal-
ist and broadcaster (Claire Rayner)
who is also Chair of the Patients As-
sociation. n = 285
Costs Average cost per attender was £145.
12 for telephone call, £14.29 for letter
from commissioner and £37.14 for let-
ter from celebrity
Oscarsson 2007 1. Control. No intervention. n = 400
2. Intervention included invitation
letters, telephone interviews and
promotive efforts for having a cervi-
cal smear taken. n = 400
Costs Cost of extra Pap smear gained was cal-
culated 151.36EURO. The cost of a
smear in the intervention group was
calculated at 66.87EURO each and 16.
63EURO in the control group
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A P P E N D I C E S
Appendix 1. Updated MEDLINE search strategy
Medline Ovid 2000-March week 2 2009
1. Vaginal Smears/
2. (vagina* adj5 smear*).mp.
3. (pap* adj5 (test* or smear*)).mp.
4. (cervi* adj5 (smear* or screen*)).mp.
5. ((cytology or cytobrush) and cervi*).mp.
6. 1 or 2 or 3 or 4 or 5
7. exp “Patient Acceptance of Health Care”/
8. (satisf* or dropout* or drop out).mp.
9. (compliance or complie* or comply*).mp.
10. (encourage* or improve* or improving or increas* or promot*).mp.
11. (uptake or particip* or nonattend*).mp.
12. (accept* or attend* or attitude* or utilisation or utilization).mp.
13. (refus* or respon* or reluctan* or nonrespon*).mp.
14. 7 or 8 or 9 or 10 or 11 or 12 or 13
15. 6 and 14
16. randomized controlled trial.pt.
17. controlled clinical trial.pt.
18. randomized.ab.
19. randomly.ab.
20. trial.ab.
21. groups.ab.
22. 16 or 17 or 18 or 19 or 20 or 21
23. 15 and 22
key: mp=title, original title, abstract, name of substance word, subject heading word, pt=publication type, fs=floating subheading
Appendix 2. Updated Embase search strategy
Embase Ovid 1980 to 2009 wk 13
1. exp Vagina Smear/
2. (vagina* adj5 smear*).mp.
3. (pap* adj5 (test* or smear*)).mp.
4. (cervi* adj5 (smear* or screen*)).mp.
5. ((cytology or cytobrush) and cervi*).mp.
6. 1 or 2 or 3 or 4 or 5
7. exp Patient Attitude/
8. (satisf* or dropout* or drop out).mp.
9. (compliance or complie* or comply*).mp.
10. (encourage* or improve* or improving or increas* or promot*).mp.
11. (uptake or particip* or nonattend*).mp.
12. (accept* or attend* or attitude* or utilisation or utilization).mp.
13. (refus* or respon* or reluctan* or nonrespon*).mp.
14. 7 or 8 or 9 or 10 or 11 or 12 or 13
15. 6 and 14
16. exp controlled clinical trial/
17. randomized.ab.
18. randomly.ab.
19. trial.ab.
20. groups.ab.
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21. 16 or 17 or 18 or 19 or 20
22. 15 and 21
key: mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer name,
ab=abstract
Appendix 3. Updated Central search strategy
CENTRAL Issue 1 2009
1. MeSH descriptor Vaginal Smears explode all trees
2. vagina* near/5 smear*
3. pap* near/5 (test* or smear*)
4. cervi* near/5 (smear* or screen*)
5. (cytology or cytobrush) and cervi*
6. (#1 OR #2 OR #3 OR #4 OR #5)
7. satisf* or dropout* or drop out
8. compliance or complie* or comply*
9. encourage* or improve* or improving or increas* or promot*
10. uptake or particip* or nonattend*
11. accept* or attend* or attitude* or utilisation or utilization
12. refus* or respond* or reluctan* or nonrespond*
13. (#7 OR #8 OR #9 OR #10 OR #11 OR #12)
14. (#6 AND #13)
Appendix 4. LILACS search strategy
LILACS database (to 03/04/2009)
vagina$ or cervi$ [Palavras] and smear$ or screen$ [Palavras] and ( “RANDOMIZEDCONTROLLEDTRIAL” ) [Tipo de publicação]
WH A T ’ S N E W
Last assessed as up-to-date: 28 March 2011.
Date Event Description
29 March 2011 New citation required but conclusions have not changed New authors added and text amendments.
29 March 2011 New search has been performed Changes to text and new authors added.
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H I S T O R Y
Protocol first published: Issue 4, 2000
Review first published: Issue 3, 2002
Date Event Description
15 May 2002 New citation required and conclusions have changed Substantive amendment
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I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Patient Acceptance of Health Care; Mass Screening [∗utilization]; Precancerous Conditions [diagnosis]; Randomized Controlled Trials
as Topic; Reminder Systems; Uterine Cervical Neoplasms [∗diagnosis; prevention & control]; Vaginal Smears [∗utilization]
MeSH check words
Female; Humans
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